EurekaMag.com logo
+ Translate

Biology, Geography & Health: Chapter 6097

Chapter 6097 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.



Sokolova G.V.; Ziya A.V.; Abramovich A.G.; Bessarabova T.N.; Ivleva A.Ya, 1986: Pharmacokinetics of ethambutol in patients with pulmonary tuberculosis

Clarke D.W.; Steenaart N.A.E.; Slack C.J.; Brien J.F., 1986: Pharmacokinetics of ethanol and its metabolite acetaldehyde and fetolethality in the third trimester pregnant guinea pig for oral administration of acute multiple dose ethanol

Kalhorn T.F.; Bowden D.M.; Slattery J.T., 1986: Pharmacokinetics of ethanol in pigtailed macaques macaca nemestrina intersubject variability and effect of subchronic administration

Mclain D.E.; Babish J.G.; Roe D.A., 1985: Pharmacokinetics of ethanol in the ferret mustela putorius

Litvin J.; Switzer B.R., 1988: Pharmacokinetics of ethanol in the guinea pig

Trnovec T.; Soltes L.; Durisova M.; Kallay Z.; Koprda V.; Piotrovskii L.B., 1985: Pharmacokinetics of ethimizol in man


Mogilevich S.E.; Galushko S.V.; Klebanov B.M., 1987: Pharmacokinetics of ethonium administered periorally

Elferink F.; Van Der Vijgh W.J.F.; Ten Bokkel Huinink W.W.; Vermorken J.B.; Klein I.; Winograd B.; Knobf M.K.T.; Simonetti G.; Gall H.E.; Et Al, 1987: Pharmacokinetics of ethylenediaminemalonatoplatinum ii jm 40 during phase i trial

D'incalci M.; Sessa C.; Rossi C.; Roviaro G.; Mangioni C., 1985: Pharmacokinetics of etoposide in gestochoriocarcinoma

D'incalci M.; Rossi C.; Zucchetti M.; Urso R.; Cavalli F.; Mangioni C.; Willems Y.; Sessa C., 1986: Pharmacokinetics of etoposide in patients with abnormal renal and hepatic function

Larsen F.G.; Jakobsen P.; Larsen C.G.; Kragballe K.; Nielsen Kudsk F., 1988: Pharmacokinetics of etretin and etretinate during long term treatment of psoriasis patients

Takabatake T.; Ohta O.; Maekawa M.; Yamamoto Y.; Ishida Y.; Hara H.; Nakamura S.; Ushiogi Y.; Kawabata M.; Hashimoto N.; Hattori N., 1985: Pharmacokinetics of famotidine a new h 2 receptor antagonist in relation to renal function

Kroemer H.; Klotz U., 1987: Pharmacokinetics of famotidine in man

Caccia S.; Conforti I.; Duchier J.; Garattini S., 1985: Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given d fenfluramine and dl fenfluramine for 15 days

Duthie D.J.R.; Mclaren A.D.; Nimmo W.S., 1986: Pharmacokinetics of fentanyl during constant rate intravenous infusion for the relief of pain after surgery

Lampl E.; Garen C.; Levron P.; Pathier D.; Cousin M.T., 1986: Pharmacokinetics of fentanyl given by the epidural route in women in labor

Koren G.; Crean P.; Goresky G.V.; Klein J.; Macleod S.M., 1984: Pharmacokinetics of fentanyl in children with renal disease

Koehntop D.E.; Rodman J.H.; Brundage D.M.; Hegland M.G.; Buckley J.J., 1986: Pharmacokinetics of fentanyl in neonates

Hudson R.J.; Thomson I.R.; Cannon J.E.; Friesen R.M.; Meatherall R.C., 1986: Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery

Singleton M.A.; Rosen J.I.; Fisher D.M., 1988: Pharmacokinetics of fentanyl in the elderly

Sakamoto H.; Hirose T.; Mine Y., 1985: Pharmacokinetics of fk 027 in rats and dogs

Bailie G.R.; Waldek S., 1988: Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis

Braun J.; Kollert J.R.; Becker J.U., 1987: Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function

Achari R.; Hulse J.D.; Drissel D.; Matier W.L., 1985: Pharmacokinetics of flestolol in man preliminary data

Lentjes E.G.W.M.; Van Ginneken C.A.M., 1987: Pharmacokinetics of flufenamic acid in man

Becherucci C.; Palmi M.; Segre G., 1985: Pharmacokinetics of flunitrazepam in rats studied by a radioreceptor assay

Lopatta F.; Vecsei P.; Taeuber U.; Haack D., 1986: Pharmacokinetics of fluocortolone during long term treatment of patients with rheumatic and hematological diseases

Legler U.F., 1986: Pharmacokinetics of fluocortolone in man

Hattab F.N., 1988: Pharmacokinetics of fluoride absorbed from dried seafoods by healthy adults

Geng B Q.; Zhu Y L., 1988: Pharmacokinetics of fluorouracil by intravenous or intraarterial injections

Abrams S.M.L.; Baker L.R.I.; Crome P.; White A.S.T.; Johnston A.; Ankier S.I.; Warrington S.J.; Turner P.; Niebch G., 1988: Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment

Szpunar, G. J.; Albert, K. S.; Bole, G. G.; Dreyfus, J. N.; Lockwood, G. F.; Wagner, J. G., 1987: Pharmacokinetics of flurbiprofen in man i. area dose relationships

Ogiso T.; Iwaki M.; Ohtsuki N., 1985: Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats

Bouchet J.L.; Quentin C.; Albin H.; Vincon G.; Guillon J.; Martin Dupont P., 1985: Pharmacokinetics of fosfomycin in hemodialyzed patients

Thomas E.W.; Bopp B.A., 1984: Pharmacokinetics of fostedil a new calcium antagonist in beagle dogs following oral and intravenous administration

Palm M.; Mattsson C., 1987: Pharmacokinetics of fragmin a comparative study in the rabbit of its high and low affinity forms for antithrombin

Herngren L.; Ehrnebo M.; Broberger U., 1987: Pharmacokinetics of free and total flucloxacillin in newborn infants

Van Der Vijgh W.J.F.; Elferink F.; Vermorken J.B.; Ten Bokkel Huinink W.W.; Klein I.; Gall H.E.; Simonetti G.; Mcvie J.G.; Pinedo H.M., 1988: Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua 1 1 bisaminomethylcyclohexane sulfatoplatinum ii spiroplatin during a phase i trial

Waller E.S.; Massarella J.W.; Tomkiw M.S.; Smith R.V.; Doluisio J.T., 1985: Pharmacokinetics of furosemide after 3 different single oral doses

Westra P.; Van Thiel M.J.S.; Vermeer G.A.; Soeterbroek A.M.; Scaf A.H.J.; Claessens H.A., 1986: Pharmacokinetics of galanthamine a long acting anticholinesterase drug in anesthetized patients

Mihailova D.; Yamboliev I., 1986: Pharmacokinetics of galanthamine hydrobromide nivalin following single intravenous and oral administration in rats

Trnovec T.; Durisova M.; Bezek S.; Kallay Z.; Navarova J.; Tomcikova O.; Kettner M.; Faltus F.; Erichleb M., 1984: Pharmacokinetics of gentamicin administered intratracheally or as an inhalation aerosol to guinea pigs

Jernigan A.D.; Wilson R.C.; Hatch R.C.; Kemp D.T., 1988: Pharmacokinetics of gentamicin after intravenous intramuscular and subcutaneous administration in cats

Meunier F.; Van Der Auwera P.; Schmitt H.; De Maertelaer V.; Klastersky J., 1987: Pharmacokinetics of gentamicin after iv infusion or iv bolus

Wajima R.; Yonemura D.; Kawasaki K.; Torisaki M.; Mochizuki K., 1986: Pharmacokinetics of gentamicin after vitrectomy

Haddad N.S.; Pedersoli W.M.; Ravis W.R.; Fazeli M.H.; Carson R.L.Jr, 1985: Pharmacokinetics of gentamicin at steady state in ponies serum urine and endometrial concentrations

Jernigan A.D.; Hatch R.C.; Wilson R.C.; Brown J.; Tuler S.M., 1988: Pharmacokinetics of gentamicin in cats given escherichia coli endotoxin

Setser M.D., 1985: Pharmacokinetics of gentamicin in channel catfish ictalurus punctatus

Gonzalez Martin G.; Bravo I.; Vargas H.; Arancibia A., 1986: Pharmacokinetics of gentamicin in children with nephrotic syndrome

Samotra K.; Gupte S.; Raina R.K., 1985: Pharmacokinetics of gentamicin in protein energy malnutrition

Clarke C.R.; Short C.R.; Hsu R C.; Baggot J.D., 1985: Pharmacokinetics of gentamicin in the calf developmental changes

Ikegami H.; Shima K.; Tanaka A.; Tahara Y.; Hirota M.; Kumahara Y., 1985: Pharmacokinetics of glibenclamide heterogeneity in its absorption

Kobayashi K.; Kimura M.; Sakoguchi T.; Hase A.; Matsuoka A.; Kaneko S., 1984: Pharmacokinetics of gliclazide in healthy and diabetic subjects

Setnikar I.; Giacchetti C.; Zanolo G., 1986: Pharmacokinetics of glucosamine in the dog and man

Blagodatskikh, S. B.; Piotrovskii, V. K.; Metelitsa, V. I.; Ryabokon', O. S.; Martsevich, S. Yu, 1987: Pharmacokinetics of glycerol trinitrate nitroglycerin in chronic ischemic heart disease patients following sublingual administration

Melethil S.; Schoepp D., 1987: Pharmacokinetics of gold sodium thiomalate in rabbits

Handelsman D.J.; Jansen R.P.S.; Boylan L.M.; Spaliviero J.A.; Turtle J.R., 1984: Pharmacokinetics of gonadotropin releasing hormone comparison of subcutaneous and intravenous routes

Karttunen P.; Mannisto P.T.; Tukiainen H.; Uusitupa M.; Nissinen E., 1988: Pharmacokinetics of graded single doses of the novel antitussive compound vadocaine hydrochloride in healthy male volunteers

Schafer Korting M., 1987: Pharmacokinetics of griseofulvin in blood and skin suction blister fluid of rats

Kiechel J.R., 1986: Pharmacokinetics of guanfacin in patients with impaired renal function and in some elderly patients

Fillastre J.P.; Leroy A.; Humbert G.; Moulin B.; Bernadet P.; Josse S., 1987: Pharmacokinetics of habekacin in patients with renal insufficiency

Cheng Y.F.; Paalzow L.K.; Bondesson L.; Ekblom B.; Eriksson K.; Eriksson S.O.; Lindberg A.; Lindstrom L., 1987: Pharmacokinetics of haloperidol in psychotic patients

Palm M.; Mattsson C., 1987: Pharmacokinetics of heparin and low molecular weight heparin fragment fragmin in rabbits with impaired renal or metabolic clearance

Emanuele R.M.; Racanelli A.; Fareed J., 1988: Pharmacokinetics of heparins differing in mean molecular weight using a xa amidolytic and heptest clotting method

Wickes A.D.; Howell S.B., 1985: Pharmacokinetics of hexamethylmelamine administered via the intraperitoneal route in an oil emulsion vehicle

Gordon I.L.; Kar R.; Opfell R.W.; Wile A.G., 1987: Pharmacokinetics of hexamethylmelamine in intralipid following hepatic regional administration in rabbits

Awidi A.; Al Turk W.A.; Madanat F.; Othman S.; Shaheen O., 1988: Pharmacokinetics of high and moderate intravenous doses of methotrexate

Van Den Ouweland F.A.; Jansen P.A.F.; Tan Y.; Van De Putte L.B.A.; Van Ginneken C.A.M.; Gribnau F.W.J., 1988: Pharmacokinetics of high dosage naproxen in elderly patients

Woolf R.A.; Koup J.R.; Smith A.L.; Hilman B.C.; Goldmann D.; Williams Warren J., 1985: Pharmacokinetics of high dose azlocillin sodium in patients with cystic fibrosis

Yamamoto N.; Yanagi K.; Matuyama H.; Shimizu K.; Mitsui H.; Shimabukuro T.; Yamamoto M.; Sakatoku J.; Fujita T.; Matsuoka K., 1987: Pharmacokinetics of high dose cisplatin administration relationship between pharmacokinetics and administration schedule

Holthuis, J. J. M.; Postmus, P. E.; Van-Oort, W. J.; Hulshoff, B.; Verleun, H.; Sleijfer, D. T.; Mulder, N. H., 1986: Pharmacokinetics of high dose etoposide vp 16 213

Canal P.; Roche H.; Pasquier M.; Bugat R.; Berg D.; Soula G.; Carton M., 1987: Pharmacokinetics of high dose iv alizapride in prevention of cisplatin induced emesis

Hersh M.R.; Ludden T.M.; Kuhn J.G.; Knight W.A.IIi, 1983: Pharmacokinetics of high dose melphalan

Tranchand B.; Biron P.; Mercatello A.; Philip T.; Ardiet C., 1988: Pharmacokinetics of high dose melphalan 200 mg m 2 in a patient with total renal failure

Bayliff C.D.; Schwartz M.L.; Hardy B.G., 1985: Pharmacokinetics of high dose pentobarbital in severe head trauma

Zhou S L.; Huang A H.; Cao Z L.; Yang M J., 1986: Pharmacokinetics of home made cefotaxime sodium in patients with normal and impaired renal and hepatic functions

Chen Z.; Lu Y.; Zhang H Y., 1987: Pharmacokinetics of homemade rifapentine in patients with acute pulmonary infections

Lu K.; Savaraj N.; Feun L.G.; Zhengang G.; Umsawasdi T.; Loo T.L., 1988: Pharmacokinetics of homoharringtonine in dogs

Girard P.; Cohen R.; Sassolas G.; Harthe C.; Cabrera P.; Boissel J.P., 1987: Pharmacokinetics of human growth hormone releasing factor hgrf 44 amide in normal men after intravenous administration of a large range of doses

Bocci V.; Pessina G.P.; Pacini A.; Paulesu L.; Muscettola M.; Naldini A.; Lunghetti G., 1985: Pharmacokinetics of human lymphoblastoid interferon in rabbits

Wills R.J.; Soike K.F., 1988: Pharmacokinetics of human recombinant interferon alpha i after iv infusion and im injection in african green monkeys

Wang Y E.; Feng J.; Lu W H.; Tang X C., 1988: Pharmacokinetics of huperzine a in rats and mice

Parab P.V.; Ritschel W.A.; Coyle D.E.; Gregg R.V.; Denson D.D., 1988: Pharmacokinetics of hydromorphone after intravenous peroral and rectal administration to human subjects

Jaillon P.; Poirier J.M.; Lecocq B.; Jarreau C.; Pays M.; Richard M.O.; Cheymol G., 1986: Pharmacokinetics of hydroxy 3 s dihydroquinidine in healthy volunteers after intravenous and oral administration

Oelschlaeger, H.; Rothley, D.; Schmidt, W., 1988: Pharmacokinetics of hypolipidemic agents iv. metabolism of the hypolipidemic agent ciprofibrate 2 4 2 2 dichlorocyclopropylphenoxy 2 methylpropanoic acid

Salvadeo A.; Villa G.; Bovio G.; Pocchiari F.; Pataccini R.; Longo A.; Ventresca G.P., 1988: Pharmacokinetics of ibopamine in patients with renal impairment

Jamali F.; Singh N.N.; Pasutto F.M.; Russell A.S.; Coutts R.T., 1988: Pharmacokinetics of ibuprofen enantiomers in humans following oral administration of tablets with different absorption rates

Wagner, J. G.; Albert, K. S.; Szpunar, G. J.; Lockwood, G. F., 1984: Pharmacokinetics of ibuprofen in man 4. absorption and disposition

Gambaro V.; Caligara M.; Benvenuti C.; Scaroni C., 1985: Pharmacokinetics of ibuprofen microencapsulated granules

Gillies H.C.; Herriott D.; Liang R.; Ohashi K.; Rogers H.J.; Harper P.G., 1987: Pharmacokinetics of idarubicin 4 demethoxydaunorubicin imi 30 nsc 256439 following intravenous and oral administration in patients with advanced cancer

Robert J.; Rigal Huguet F.; Harousseau J.L.; Pris J.; Huet S.; Reiffers J.; Hurteloup P.; Tamassia V., 1987: Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patients

Toon S.; Hopkins K.J.; Garstang F.M.; Aarons L.; Rowland M., 1987: Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly

Reed M.D.; Stern R.C.; O'brien C.A.; Yamashita T.S.; Myers C.M.; Blumer J.L., 1985: Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis

Freij B.J.; Mccracken G.H.Jr; Olsen K.D.; Threlkeld N., 1985: Pharmacokinetics of imipenem cilastatin in neonates

Somani P.; Freimer E.H.; Gross M.L.; Higgins J.T.Jr, 1988: Pharmacokinetics of imipenem cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis

Devane C.L.; Simpkins J.W., 1985: Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose

Wilson M.A.; Roy E.J., 1986: Pharmacokinetics of imipramine are affected by age and sex in rats

Rosenblum M.G.; Murray J.L.; Haynie T.P.; Glenn H.J.; Jahns M.F.; Benjamin R.S.; Frincke J.M.; Carlo D.J.; Hersh E.M., 1985: Pharmacokinetics of indium 111 labeled anti p 97 monoclonal antibody in patients with metastatic malignant melanoma

Hnatowich D.J.; Gionet M.; Rusckowski M.; Siebecker D.A.; Roche J.; Shealy D.; Mattis J.A.; Wilson J.; Mcgann J.; Et Al, 1987: Pharmacokinetics of indium 111 labeled oc 125 antibody in cancer patients compared with the 19 9 antibody

Naumenko A.Z.; Korsunskii V.N.; Popov V.I.; Starovoitova L.P.; Mechev D.S., 1986: Pharmacokinetics of indium 113m indifor

Kurowski M., 1985: Pharmacokinetics of indoprofen in elderly patients following repeated oral administration

Pierce D.M.; Warrington S.J.; Franklin R.A., 1988: Pharmacokinetics of indoramin and its 6 hydroxylated metabolite after repeated oral dosing

Carpenter R.L.; Eger E.I.II.; Johnson B.H.; Unadkat J.D.; Sheiner L.B., 1986: Pharmacokinetics of inhaled anesthetics in humans measurements during and after the simultaneous administration of enflurane halothane isoflurane methoxyflurane and nitrous oxide

Vaisman N.; Koren G.; Goldstein D.; Canny G.J.; Tan Y.K.; Soldin S.; Pencharz P., 1987: Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults

Tota G.; La Marca F.; Signorini G., 1987: Pharmacokinetics of instilled fluids in the human eye the effects induced by two topical applications of different drugs or of the same collyrium

Ravis W.R.; Comerci C.; Ganjam V.K., 1986: Pharmacokinetics of insulin following intravenous and subcutaneous administration in canines

Selam J.L.; Raymond M.; Jacquemin J.L.; Orsetti A.; Richard J.L.; Mirouze J., 1985: Pharmacokinetics of insulin infused intraperitoneally via portable pumps

Radwanski E.; Perentesis G.; Jacobs S.; Oden E.; Affrime M.; Symchowicz S.; Zampaglione N., 1987: Pharmacokinetics of interferon alpha 2b in healthy volunteers

Gouyette A.; Apchin A.; Foka M.; Richard J M., 1986: Pharmacokinetics of intra arterial and intravenous cisplatin in head and neck cancer patients

Petersen J.; Stewart R.D.M.; Catto G.R.D.; Edward N., 1985: Pharmacokinetics of intraperitoneal cefotaxime treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis

Bonati M.; Traina G.L.; Gentile M.G.; Fellin G.; Rosina R.; Cavenaghi L.; Buniva G., 1988: Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis

Chan T.C.K.; Coppoc G.L.; Zimm S.; Cleary S.; Howell S.B., 1988: Pharmacokinetics of intraperitoneally administered dipyridamole in cancer patients

Sjostrom S.; Tamsen A.; Persson M.P.; Hartvig P., 1987: Pharmacokinetics of intrathecal morphine and meperidine in humans

Munsat T.L.; Taft J.; Jackson I.M.D., 1987: Pharmacokinetics of intrathecal trh

Patel I.H.; Bornemann L.D.; Brocks V.M.; Fang L.S.T.; Tolkoff Rubin N.E.; Rubin R.H., 1985: Pharmacokinetics of intravenous amdinocillin in healthy subjects and patients with renal insufficiency

White N.J.; Looareesuwan S.; Edwards G.; Phillips R.E.; Karbwang J.; Nicholl D.D.; Bunch C.; Warrell D.A., 1987: Pharmacokinetics of intravenous amodiaquine

Albin H.; Ragnaud J.M.; Demotes Mainard F.; Vincon G.; Couzineau M.; Wone C., 1986: Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis

Bouchet, J. L.; Albin, H.; Quentin, C.; De-Barbeyrac, B.; Vincon, G.; Martin-Dupont, P.; Potaux, L.; Aparicio, M., 1988: Pharmacokinetics of intravenous and intraperitoneal fosfomycin in continuous ambulatory peritoneal dialysis

Albin H.; Ragnaud J.M.; Demotes Mainard F.; Vincon G.; Wone C., 1986: Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis

Chang T.; Black A.; Dunky A.; Wolf R.; Sedman A.; Latts J.; Welling P.G., 1988: Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers

Morgan, D. J.; Paull, J. D.; Richmond, B. H.; Wilson-Evered, E.; Ziccone, S. P., 1986: Pharmacokinetics of intravenous and oral salbutamol and its sulfate conjugate

James C.A.; Mant T.G.K.; Rogers H.J. , 1987: Pharmacokinetics of intravenous and oral sodium 2 mercaptoethanesulfonate mesna in normal subjects

Jonsson M.; Walder M., 1986: Pharmacokinetics of intravenous antibiotics in acutely ill elderly patients

Lesko L.J.; Benotti J.R.; Alpert J.S.; Brady P.M.; Mccue J.E.; Weiner B.H.; Ockene I.S., 1986: Pharmacokinetics of intravenous bepridil in patients with coronary disease

Johnson C.A.; Zimmerman S.W.; Bayer W.; Craig W.A., 1985: Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis

Koren G.; Zarfin Y.; Maresky D.; Spiro T.E.; Macleod S.M., 1986: Pharmacokinetics of intravenous clindamycin in newborn infants

Andersen H.B.; Christensen B.; Findlay J.W.A.; Janssen J.A., 1986: Pharmacokinetics of intravenous intrathecal and epidural morphine and fentanyl in the goat

Fauser B.C.J.M.; Rolland R.; Kremer J.A.M.; Doesburg W.H.; Thomas C.M.G., 1987: Pharmacokinetics of intravenous lhrh administration in men effects of various dosages

Bright J.E.; Marrs T.C., 1988: Pharmacokinetics of intravenous potassium cyanide

Arboix M.; Puigdemont A.; Moya A.; Cinca J., 1985: Pharmacokinetics of intravenous propafenone in patients with episodes of paroxysmal supraventricular tachycardia

Nissenson A.R.; Wilson C.; Holazo A., 1987: Pharmacokinetics of intravenous trimethroprim sulfamethoxazole during hemodialysis

Drusano G.L.; Weir M.; Forrest A.; Plaisance K.; Emm T.; Standiford H.C., 1987: Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function

Ammon H.P.T.; Melien M.C.M.; Verspohl E.J., 1986: Pharmacokinetics of intravenously administered glutathione in the rat

Tokola O.; Tenhunen R.; Volin L.; Mustajoki P., 1986: Pharmacokinetics of intravenously administered heme arginate

Bree F.; Houin G.; Barre J.; Moretti J L.; Wirquin V.; Tillement J P., 1986: Pharmacokinetics of intravenously administered iodine 125 labeled human alpha 1 acid glycoprotein

Strong J.M.; Collins J.M.; Lester C.; Poplack D.G., 1986: Pharmacokinetics of intraventricular and intravenous thiotepa in rhesus monkeys and humans

Duchin K.L.; Drayer B.P.; Ross M.; Allen S.; Frantz M., 1986: Pharmacokinetics of iopamidol after intrathecal administration in humans

Geisser P.; Mueller A., 1987: Pharmacokinetics of iron salts and ferric hydroxide carbohydrate complexes

Saeki S., 1987: Pharmacokinetics of isoflurane in a semiclosed to closed system

Kergueris M.F.; Bourin M.; Le Normand Y.; Larousse C.; Rembeaux A., 1986: Pharmacokinetics of isoniazid in advanced age

Kergueris M.F.; Bourin M.; Larousse C., 1986: Pharmacokinetics of isoniazid influence of age

Peter H.; Wiegand H.J.; Bolt H.M.; Greim H.; Walter G.; Berg M.; Filser J.G., 1987: Pharmacokinetics of isoprene in mice rats

Evers J.; Bonn R.; Boertz A.; Cawello W.; Luckow V.; Fey M.; Aboudan F.; Dickmans H A., 1987: Pharmacokinetics of isosorbide 5 nitrate during hemodialysis and peritoneal dialysis

Evers J.; Krakamp B.; Klimkait W.; Dickmans H.A.; Maddock J.; Luckow V.; Cawello W.; Weiss M., 1986: Pharmacokinetics of isosorbide 5 nitrate in renal failure

Santoni Y.; Iliadis A.; Cano J P.; Luccioni R.; Frances Y., 1986: Pharmacokinetics of isosorbide dinitrate and its mononitrate metabolites after intravenous infusion

Gandini R.; Cunietti C.; Assereto R.; Castoldi D.; Tofanetti O.; Baggio E., 1987: Pharmacokinetics of isosorbide mononitrate in a new sustained release oral form in comparison with a conventional formulation

Bjorkman S.; Gabrielsson J.; Quaynor H.; Corbey M., 1987: Pharmacokinetics of iv and rectal methohexitone in children

Prichard R.K.; Steel J.W.; Lacey E.; Hennessy D.R., 1985: Pharmacokinetics of ivermectin in sheep following intravenous intraabomasal or intraruminal administration

Okolicsanyi L.; Venuti M.; Strazzabosco M.; Biral A.; Orlando R.; Iemmolo R.M.; Nassuato G.; Muraca M.; Padrini G.; Miglioli P.A.; Berti T., 1985: Pharmacokinetics of josamycin in patients with liver cirrhosis and gilberts syndrome after repeated doses

Fox K.E.; Russell N.J., 1987: Pharmacokinetics of kanamycin in the bullfrog rana catesbeiana

Hanna R.M.; Borchard R.E.; Schmidt S.L., 1988: Pharmacokinetics of ketamine hydrochloride and metabolite i in the cat a comparison of iv im and rectal administration

Heykants J.; Van Peer A.; Woestenborghs R.; Gould S.; Mills J., 1986: Pharmacokinetics of ketanserin and its metabolite ketanserinol in man after intravenous intramuscular and oral administration

Persson B.; Pettersson A.; Hedner T., 1987: Pharmacokinetics of ketanserin in patients with essential hypertension

Foster R.T.; Jamali F.; Russell A.S.; Alballa S.R., 1988: Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses

El Yazigi A.; Al Saleh I., 1987: Pharmacokinetics of khellin in rabbits oral intravenous and intramuscular administrations

Gasparovic V.; Milutinovic S.; Plavsic F.; Gjurasin M.; Molnar V., 1988: Pharmacokinetics of labetalol in patients on hemodialysis

Matsubara T.; Otsubo S.; Ogawa A.; Oka T., 1987: Pharmacokinetics of latamoxef and n methyltetrazolethiol in rats associated with the development of disulfiram like effects

Mcguire B.W.; Sia L.L.; Leese P.T.; Gutierrez M.L.; Stokstad E.L.R., 1988: Pharmacokinetics of leucovorin calcium after intravenous intramuscular and oral administration

Naqvi R.H.; Mitra S.B.; Saksena I F.; Lindberg M.C., 1984: Pharmacokinetics of levo norgestrel in the rat

Burm A.G.L.; De Boer A.G.; Van Kleef J.W.; Vermeulen N.P.E.; De Leede L.G.J.; Spierdijk J.; Breimer D.D., 1988: Pharmacokinetics of lidocaine and bupivacaine and stable isotope labelled analogues a study in healthy volunteers

Takahashi S.; Imamura T.; Kaise A.; Hashimoto Y.; Amaha K., 1987: Pharmacokinetics of lidocaine during cardiopulmonary bypass

Burm A.G.L.; Vermeulen N.P.E.; Van Kleef J.W.; De Boer A.G.; Spierdijk J.; Breimer D.D., 1987: Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration simultaneous investigation of absorption and disposition kinetics using stable isotopes

Ecoffey C.; Desparmet J.; Berdeaux A.; Maury M.; Giudicelli J.F.; Saint Maurice C., 1984: Pharmacokinetics of lignocaine in children following caudal anesthesia

Gadalla M.A.F.; Sabri S., 1985: Pharmacokinetics of lignocaine in humans after perioral injections

Van Schaik B.A.M.; Geyskes G.G.; Van Der Wouw P.A.; Van Rooij H.H.; Porsius A.J., 1988: Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function

Hardy B.G.; Shulman K.I.; Mackenzie S.E.; Kutcher S.P.; Silverberg J.D., 1987: Pharmacokinetics of lithium in the elderly

Ford S.; Ankier S.I.; Corless D.; Bevan C.D.; Pidgen A.W.; Robinson J.D.; Rangedara D.C., 1987: Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients

Kreis W.; Chaudhri F.; Chan K.; Allen S.; Budman D.R.; Schulman P.; Weiselberg L.; Freeman J.; Deere M.; Vinciguerra V., 1985: Pharmacokinetics of low dose 1 beta d arabinofuranosylcytosine given by continuous intravenous infusion over twenty one days

Chan K.; Tse J.; Jennings F.; Orme M.L., 1987: Pharmacokinetics of low dose intravenous pethidine in patients with renal dysfunction

Foth H.; Kahl R.; Kahl G.F., 1988: Pharmacokinetics of low doses of benzo a pyrene in the rat

Setnikar I.; Chiste R.; Makovec F.; Rovati L.C.; Warrington S.J., 1988: Pharmacokinetics of loxiglumide after single intravenous or oral doses in man

Schreiner A.; Digranes A., 1985: Pharmacokinetics of lymecycline and doxycycline in serum and suction blister fluid

Siegel J.P.; Lane H.C.; Stocks N.I.; Quinnan G.V.Jr; Fauci A.S., 1985: Pharmacokinetics of lymphocyte derived and recombinant dna derived interleukin 2 after intravenous administration to patients with the acquired immunodeficiency syndrome

Bolan J.C.; Craft J.B.Jr; Patch J.H.; Woolf W.A.; Fabro S.; Lahijani J.; Mazel P., 1985: Pharmacokinetics of magnesium sulfate in the sheep model

Moukhtar I.; Nawishy S.; Sabbour M., 1987: Pharmacokinetics of mecillinam after a single intravenous dose in patients with impaired renal function

Lane E.A.; Moss H.B., 1985: Pharmacokinetics of melatonin in man first pass hepatic metabolism

Briele H.A.; Djuric M.; Jung D.T.; Mortell T.; Patel M.K.; Das Gupta T.K., 1985: Pharmacokinetics of melphalan in clinical isolation perfusion of the extremities

Benckhuijsen C.; Varossieau F.J.; Hart A.A.M.; Wieberdink J.; Noordhoek J., 1986: Pharmacokinetics of melphalan in isolated perfusion of the limbs

Naguib M.; Famewo C.E.; Absood A., 1986: Pharmacokinetics of meperidine in spinal anesthesia

Krause W.; Kampf D.; Fischer H C., 1984: Pharmacokinetics of mepindolol in patients with chronic renal failure

Murray G.R.; Franklin R.A.; Graham D.F.; Lewis R.R.; Bolland M.E., 1987: Pharmacokinetics of meptazinol after parenteral administration in the elderly

Norbury H.M.; Franklin R.A.; Graham D.F.; Sinha B., 1984: Pharmacokinetics of meptazinol after single and multiple oral administration to elderly patients

Okuno, A.; Yano, K.; Inyaku, F.; Suzuki, Y.; Sanae, N.; Kumai, M.; Naitoh, Y., 1987: Pharmacokinetics of methimazole in children and adolescents with graves' disease studies on plasma and intrathyroidal concentrations

Hengstmann J.H.; Hohn H., 1985: Pharmacokinetics of methimazole in humans

Okamura Y.; Shigemasa C.; Tatsuhara T., 1986: Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients

Slordal, L.; Kolmanskog, S.; Prytz, P. S.; Moe, P. J.; Aarbakke, J., 1986: Pharmacokinetics of methotrexate and 7 hydroxymethotrexate after high dose 33.6 g per square meter methotrexate therapy

Bore P.; Iliadis A.; Catalin J.; Just S.; Cano J.P., 1987: Pharmacokinetics of methotrexate and 7 hydroxymethotrexate after methotrexate infusions

Sonneveld P.; Schultz F.W.; Nooter K.; Hahlen K., 1986: Pharmacokinetics of methotrexate and 7 hydroxymethotrexate in plasma and bone marrow of children receiving low dose oral methotrexate

El Yazigi A.; Amer M.; Al Saleh I.; Martin C., 1986: Pharmacokinetics of methotrexate and its 7 hydroxy metabolite in cancer patients treated with different high methotrexate dosage regimens

Hendel J.; Nyfors A., 1984: Pharmacokinetics of methotrexate in erythrocytes in psoriasis

Kumar R.V.; Gokhale S.V.; Ambaye R.Y.; Shetty P.A., 1987: Pharmacokinetics of methotrexate in indian children and its relationship to nutritional status

Wenda K.; Scheuermann H.; Weitzel E.; Rudigier J., 1988: Pharmacokinetics of methylmethacrylate monomer during total hip replacement in man

Toutain P.L.; Koritz G.D.; Fayolle P.M.; Alvinerie M., 1986: Pharmacokinetics of methylprednisolone methylprednisolone sodium succinate and methylprednisolone acetate in dogs

Toutain P.L.; Autefage A.; Oukessou M.; Alvinerie M., 1987: Pharmacokinetics of methylprednisolone succinate methylprednisolone and lidocaine in the normal dog and during hemorrhagic shock

Bredberg U.; Eyjolfsdottir G.S.; Paalzow L.; Tfelt Hansen P.; Tfelt Hansen V., 1986: Pharmacokinetics of methysergide and its metabolite methylergometrine in man

Larsson M.; Landahl S.; Lundborg P.; Regardh C.G., 1984: Pharmacokinetics of metoprolol in healthy elderly nonsmoking individuals after a single dose and 2 weeks of treatment

Zel'vin B.M.; Polyakov P.Yu; Zimina E.S.; Dar'yalova S.L.; Kiseleva E.S.; Sokolova I.I., 1984: Pharmacokinetics of metronidazole and its effect on the body during its use as a radiosensitizer

Bergan T.; Thorsteinsson S.B., 1986: Pharmacokinetics of metronidazole and its metabolites in reduced renal function

Lau A., 1986: Pharmacokinetics of metronidazole in hospitalized patients

Houghton G.W.; Dennis M.J.; Gabriel R., 1985: Pharmacokinetics of metronidazole in patients with varying degrees of renal failure

Levy Prades R.; Philip F.; Danays T.; Serradimigni A.; Cano J.P., 1987: Pharmacokinetics of mexiletine and its hydroxymethyl metabolite after intramuscular and intravenous mexiletine administration in healthy subjects

Meyers B.R.; Srulevitch E.S.; Sacks H.S.; Hirschman S.Z.; Worner T.M.; Wormser G.P.; Jacobson J., 1986: Pharmacokinetics of mezlocillin in patients with hepatobiliary dysfunction

Clausen T.G.; Wolff J.; Hansen P.B.; Larsen F.; Rasmussen S.N.; Dixon J.S.; Crevoisier C., 1988: Pharmacokinetics of midazolam and alpha hydroxymidazolam following rectal and intravenous administration

Behne M.; Zobel R.; Asskali F.; Foerster H.; Kessler P.; Seiz W., 1987: Pharmacokinetics of midazolam during different kinds of anesthesia

Trouvin J H.; Farinotti R.; Haberer J P.; Servin F.; Chauvin M.; Duvaldestin P., 1988: Pharmacokinetics of midazolam in anesthetized cirrhotic patients

Barbhaiya R.H.; Papp E.A.; Van Harken D.R.; Smyth R.D., 1984: Pharmacokinetics of mitomycin c in dogs application of a high performance liquid chromatographic assay

Buice R.G.; Niell H.B.; Sidhu P.; Gurley B.J., 1984: Pharmacokinetics of mitomycin c in non oat cell carcinoma of the lung

Smolyanskaya A.Z.; Spasibina T.V., 1984: Pharmacokinetics of mitomycin c in oncological patients subjected to prolonged administration of the drug

Malviya V.K.; Young J.D.; Boike G.; Gove N.; Deppe G., 1986: Pharmacokinetics of mitomycin c in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats

Van Belle S.J.P.; De Planque M.M.; Smith I.E.; Van Oosterom A.T.; Schoemaker T.J.; Deneve W.; Mcvie J.G., 1986: Pharmacokinetics of mitoxantrone in humans following single agent infusion or intra arterial injection therapy or combined agent infusion therapy

Covell, D. G.; Barbet, J.; Holton, O. D.; Black, C. D. V.; Parker, R. J.; Weinstein, J. N., 1986: Pharmacokinetics of monoclonal immunoglobulin g 1 fab' 2 and fab' in mice

Drost R.H.; Ionescu T.I.; Van Rossum J.M.; Maes R.A.A., 1986: Pharmacokinetics of morphine after epidural administration in man

Tanguy M.; Malledant Y.; Le Verge R.; Gibassier D.; Saint Marc C., 1987: Pharmacokinetics of morphine after prolonged continuous infusion

Garrett, E. R.; El-Koussi, A. E. D. A., 1985: Pharmacokinetics of morphine and its surrogates 5. naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose

Garrett, E. R.; Chandran, V. R., 1985: Pharmacokinetics of morphine and its surrogates 6. bioanalysis solvolysis kinetics solubility pk' a values and protein binding of buprenorphine

Garrett, E. R.; Derendorf, H.; Mattha, A. G., 1985: Pharmacokinetics of morphine and its surrogates vii. high performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs

Garrett, E. R.; Shyu, W. C.; Ulubelen, A., 1986: Pharmacokinetics of morphine and its surrogates viii. naloxone and naloxone conjugate pharmacokinetics in dogs as a function of dose and as affected by simultaneously administered morphine

Melzacka M.; Nesselhutt T.; Havemann U.; Vetulani J.; Kuschinsky K., 1985: Pharmacokinetics of morphine in striatum and nucleus accumbens relationship to pharmacological actions

Shelly M.P.; Cory E.P.; Park G.R., 1986: Pharmacokinetics of morphine in two children before and after liver transplantation

Trenk D.; Wagner F.; Jaehnchen E.; Plaenitz V., 1987: Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers

Spyker D.A.; Richmond J.D.; Scheld W.M.; Bolton W.K., 1985: Pharmacokinetics of multiple dose cefoperazone in hemodialysis patients

Flick D.A.; Gifford G.E., 1986: Pharmacokinetics of murine tumor necrosis factor

Borgstrom, L.; Kagedal, B.; Paulsen, O., 1986: Pharmacokinetics of n acetylcysteine in man

Atkinson A.J.Jr; Ruo T.I., 1986: Pharmacokinetics of n acetylprocainamide

Pullar T.; Haigh J.R.M.; Peaker S.; Feely M.P., 1987: Pharmacokinetics of n desmethylclobazam in healthy volunteers and patients with epilepsy

Gombar C.T.; Pylypiw H.M.Jr; Harrington G.W., 1987: Pharmacokinetics of n nitrosodimethylamine in beagles

Elfner R.; Achtert G.; Hausleiter H.J.; Lentz A.; Heene D.L., 1987: Pharmacokinetics of n propylajmaline bitartrate in elderly patients with ventricular ectopic activity

Zekorn C.; Achtert G.; Hausleiter H.J.; Moon C.H.; Eichelbaum M., 1985: Pharmacokinetics of n propylajmaline in relation to polymorphic sparteine oxidation

Rafikov R.Z.; Sakhibov A.D.; Akhmedzhanov R.I.; Aliev Kh U., 1986: Pharmacokinetics of n vinylpyrrolidone and acrylic acid copolymers 1

Adams, J. D.; Lavoie, E. J.; O'mara-Adams, K. J.; Hoffmann, D.; Carey, K. D.; Marshall, M. V., 1985: Pharmacokinetics of n' nitrosonornicotine and 4 methylnitrosamino 1 3 pyridyl 1 butanone in laboratory animals

Treiman D.M.; Gunawan S., 1987: Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy

Wilson S.J.; Errick J.K.; Balkon J., 1986: Pharmacokinetics of nalbuphine during parturition

Bressolle F.; Bres J., 1985: Pharmacokinetics of naphthazone in the dog

Franssen M.J.A.M.; Tan Y.; Van De Putte L.B.A.; Van Ginneken C.A.M.; Gribnau F.W.J., 1986: Pharmacokinetics of naproxen at two dosage regimens in healthy volunteers

Mcverry R.M.; Lethbridge J.; Martin N.; Mukerjee S.K.; Littler T.; Tallis R.; Sibeon R.; Orme M.L.E., 1986: Pharmacokinetics of naproxen in elderly patients

Denis C.; Denis J., 1988: Pharmacokinetics of netilmicin in cirrhotic patients with or without ascites

Arancibia A.; Matus M.; Gentili I.; Ruiz I.; Thambo S.; Icarte A.; Gonzalez C.; Chavez H., 1986: Pharmacokinetics of netilmicin in healthy volunteers and patients with impaired renal function

Basile C.; Di Maggio A.; Curino E.; Scatizzi A., 1985: Pharmacokinetics of netilmicin in hypertonic hemodiafiltration and standard hemodialysis

Kuhn R.J.; Nahata M.C.; Powell D.A.; Bickers R.G., 1986: Pharmacokinetics of netilmicin in premature infants

Herrero, A.; Rius-Alarco, F.; Garcia-Diez, J. M.; Mahiques, E.; Domingo, J. V., 1988: Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis

Fillastre J.P.; Humbert G.; Leroy A.; Borsa F.; Hannedouche T., 1986: Pharmacokinetics of netilmicin in the elderly

Tanaka K., 1984: Pharmacokinetics of new cephems latamoxef cefotaxime in neonates and children

Kyerematen G.A.; Taylor L.H.; Debethizy J.D.; Vesell E.S., 1988: Pharmacokinetics of nicotine and 12 metabolites in the rat application of a new radiometric high performance liquid chromatography assay

Pasanisi F.; Meredith P.A.; Reid J.L., 1985: Pharmacokinetics of nifedipine

Ene M.D.; Roberts C.J.C., 1987: Pharmacokinetics of nifedipine after oral administration in chronic liver disease

Kuroda T.; Yokoyama T.; Umeda T.; Ohnishi N.; Kuroda K.; Inoh T.; Inatome T.; Yamaguchi A.; Asada S., 1985: Pharmacokinetics of nifedipine and prediction of plasma concentration on essential hypertensive patients

Garnier Moiroux A.; Henry J.F.; Taburet A.M.; Forette F.; Singlas E., 1987: Pharmacokinetics of nifedipine in the elderly

Tokuma Y.; Sekiguchi M.; Niwa T.; Noguchi H., 1988: Pharmacokinetics of nilvadipine a new dihydropyridine calcium antagonist in mice rats rabbits and dogs

Terakawa M.; Tokuma Y.; Shishido A.; Noguchi H., 1987: Pharmacokinetics of nilvadipine in healthy volunteers

Vinge E.; Andersson K E.; Brandt L.; Ljunggren B.; Nilsson L G.; Rosendal Helgesen S., 1986: Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid hemorrhage

Yoshimura, M.; Kojima, J.; Ito, T.; Suzuki, J., 1985: Pharmacokinetics of nipradilol k 351 a new antihypertensive agent i. studies on interspecies variation in laboratory animals

Yoshimura, M.; Kojima, J.; Ito, T.; Fujii, M.; Suzuki, J., 1985: Pharmacokinetics of nipradilol k 351 a new antihypertensive agent ii. influence of the route of administration of bioavailability in dogs

Ahr, H. J.; Krause, H. P.; Siefert, H. M.; Suwelack, D.; Weber, H., 1988: Pharmacokinetics of nisoldipine i. absorption concentration in plasma and excretion after single administration of carbon 14 nisoldipine in rats dogs monkey and swine

Ahr, H. J.; Krause, H. P.; Suwelack, D.; Weber, H., 1988: Pharmacokinetics of nisoldipine ii. distribution to and elimination from tissues and organs following single or repeated administration carbon 14 nisoldipine to rats and dogs

Scherling, D.; Karl, W.; Ahr, G.; Ahr, H. J.; Wehinger, E., 1988: Pharmacokinetics of nisoldipine iii. biotransformation of nisoldipine in rat dog monkey and man

Boelaert J.; Valcke Y.; Dammekens H.; De Vriese G.; Ahr G.; Schurgers M.; Daneels R.; Bogaert M.G., 1988: Pharmacokinetics of nisoldipine in renal dysfunction

Schultz D.S.; Deen W.M.; Karel S.F.; Wagner D.A.; Tannenbaum S.R., 1985: Pharmacokinetics of nitrate in humans role of gastrointestinal absorption and metabolism

Russo R.G.; Cattaneo M.T.; Bartosek I., 1984: Pharmacokinetics of nitrosoureas comparison of 1 3 bis 2 chloroethyl 1 nitrosourea and 1 2 chloroethyl 3 cyclohexyl 1 nitrosourea after oral and intravenous administration to rats

Bartosek I.; Russo R.G.; Cattaneo M.T., 1984: Pharmacokinetics of nitrosoureas levels of 1 3 bis 2 chloroethyl 1 nitrosourea in organs of normal and walker 256 b carcinoma bearing rats after intravenous bolus

Griffeth L.K.; Rosen G.M.; Rauckman E.J.; Drayer B.P., 1984: Pharmacokinetics of nitroxide nmr contrast agents

Loescher W.; Luettgenau H.; Schlegel W.; Krueger S., 1988: Pharmacokinetics of non steroidal anti inflammatory drugs in male rabbits after acute and chronic administration and effect of chronic treatment on seminal prostaglandins sperm quality and fertility

Sang G W.; Liu X H., 1986: Pharmacokinetics of norethindrone enanthate in 5 women after a single dose of norethindrone enanthate and estradiol valerate

Sivakumar B.; Nair K.M.; Prasad K.V.S.; Rao B.S.N., 1985: Pharmacokinetics of norethisterone and levonorgestrel in experimental iron deficiency anemia in rabbits

Puri C.P.; Vajifdar B.S.; Nayak V.G.; Dhanasekaran K.; Pongubala J.M.R.; Hamied Y.K.; Kumar T.C.A., 1987: Pharmacokinetics of norethisterone following its oral administration and by spraying it nasally or sublingually to male bonnet monkeys

Shi Y E.; He C H.; Gu Jiang; Fotherby K., 1987: Pharmacokinetics of norethisterone in humans

Arrigo G.; Cavaliere G.; D'amico G.; Passarella E.; Broccali G., 1985: Pharmacokinetics of norfloxacin in chronic renal failure

Kean W.F.; Buchanan W.W., 1987: Pharmacokinetics of nsaid with special reference to the elderly

Miller M.J.; Sipes I.G.; Perry D.F.; Carter D.E., 1985: Pharmacokinetics of o nitroanisole in fischer 344 rats

Lode H.; Hoffken G.; Olschewski P.; Sievers B.; Kirch A.; Borner K.; Koeppe P., 1987: Pharmacokinetics of ofloxacin after parenteral and oral administration

Fourtillan J.B.; Granier J.; Saint Salvi B.; Salmon J.; Surjus A.; Tremblay D.; Du Laurier M.V.; Beck S., 1986: Pharmacokinetics of ofloxacin and theophylline alone and in combination

Hoeffler D.; Koeppe P., 1988: Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function

Pearson A.D.J.; Mills S.; Amineddine H.A.; Long D.R.; Craft A.W.; Chessells J.M., 1987: Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukemia

Vaiseman N.; Koren G.; Pencharz P., 1986: Pharmacokinetics of oral and intravenous bromide in normal volunteers

Loos U.; Musch E.; Jensen J.C.; Mikus G.; Schwabe H.K.; Eichelbaum M., 1985: Pharmacokinetics of oral and intravenous rifampicin during chronic administration

Brazzell R.K.; Colburn W.A.; Aogaichi K.; Szuna A.J.; Somberg J.C.; Carliner N.; Heger J.; Morganroth J.; Winkle R.A.; Block P., 1985: Pharmacokinetics of oral cibenzoline in arrhythmia patients

Ball A.P.; Fox C.; Ball M.E.; Brown I.R.F.; Willis J.V., 1986: Pharmacokinetics of oral ciprofloxacin 100 milligrams single dose in volunteers and elderly patients

Bergan T.; Engeset A.; Olszewski W., 1986: Pharmacokinetics of oral co trimazine and the penetration of its components sulfadiazine and trimethoprim into peripheral human lymph

Back D.J.; Breckenridge A.M.; Grimmer S.F.M.; Orme M.L.; Purba H.S., 1984: Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine

El Raghy I.; Back D.J.; Makeram M.; Salem H.; Osman F.; Fathalla M.; Orme M.L.E., 1986: Pharmacokinetics of oral contraceptive steroids in egyptian women studies with ovral nordette and norminest

Grevel, J.; Nuesch, E.; Abisch, E.; Kutz, K., 1986: Pharmacokinetics of oral cyclosporin a sandimmun in healthy subjects

Laufen, H.; Leitold, M.; Yeates, R. A., 1986: Pharmacokinetics of oral glycerol 1 nitrate

Wiesel F A.; Raaflaub J.; Kettler R., 1985: Pharmacokinetics of oral moclobemide in healthy human subjects and effects on monoamine oxidase activity in platelets and excretion of urine monoamine metabolites

Chang T.; Young R.M.; Goulet J.R.; Yakatan G.J., 1985: Pharmacokinetics of oral pramiracetam in normal volunteers

Lapka R.; Marek J.; Rejholec V.; Franc Z., 1986: Pharmacokinetics of oral terguride in patients with a prolactinoma

Koysooko R.; Tuchinda M.; Habanananda S.; Pinthong T.; Wattanapermpool J.; Geadsomnuig S., 1987: Pharmacokinetics of oral theophylline in thai asthmatic children

Van Der Graaff M.; Vermeulen N.P.E.; Heij P.; Boeijinga J.K.; Breimer D.D., 1986: Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects

Smith R.V.; Waller E.S.; Doluisio J.T.; Bauza M.T.; Puri S.K.; Ho I.; Lassman H.B., 1986: Pharmacokinetics of orally administered pentoxifylline in humans

Tse F.L.S.; Jaffe J.M.; Bhuta S., 1987: Pharmacokinetics of orally administered tizanidine in healthy volunteers

Turcant A.; Granry J.C.; Allain P.; Cavellat M., 1987: Pharmacokinetics of ornidazole in neonates and infants after a single intravenous infusion

Merdjan H.; Baumelou A.; Diquet B.; Chick O.; Singlas E., 1985: Pharmacokinetics of ornidazole in patients with renal insufficiency influence of hemodialysis and peritoneal dialysis

Suwa T.; Urano H.; Tsuji A., 1987: Pharmacokinetics of oxaprozin after multiple doses

Scavone J.M.; Ochs H.R.; Greenblatt D.J.; Matlis R., 1988: Pharmacokinetics of oxaprozin in women receiving conjugated estrogen

Buelau P.; Paar W.D.; Von Unruh G.E., 1988: Pharmacokinetics of oxcarbazepine and 10 hydroxycarbazepine in the newborn child of an oxcarbazepine treated mother

Bogan J.; Benoit E.; Delatour P., 1987: Pharmacokinetics of oxfendazole in goats a comparison with sheep

Watson T.G.; Manley T.R., 1985: Pharmacokinetics of oxfendazole in red deer cervus elaphus

Perucca E.; Albrici A.; Gatti G.; Spalluto R.; Visconti M.; Crema A., 1984: Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers

Fauvelle F.; Leon A.; Niakate M.T.; Petitjean O.; Guillevin L., 1988: Pharmacokinetics of paracetamol diclofenac and vidarabine during plasma exchange

Stankowska Chomicz A.; Gawronska Szklarz B., 1987: Pharmacokinetics of paracetamol in ischemic cerebral apoplexy

Bortolotti A.; Jiritano L.; Bonati M., 1985: Pharmacokinetics of paraxanthine 1 of the primary metabolites of caffeine in the rat

Gill M.A.; Kern J.W.; Chenella F.C.; Heseltine P.N.R.; Yellin A.E.; Foulds G.; Berne T.V., 1984: Pharmacokinetics of parenteral sulbactam in patients with appendicitis

Staniforth D.H.; Coates P.E.; Davies B.E.; Horton R., 1986: Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid timentin

Sultan E.; Richard C.; Pezzano M.; Auzepy P.; Singlas E., 1988: Pharmacokinetics of pefloxacin and amikacin administered simultaneously to intensive care patients

Hoeffler D.; Schaefer I.; Koeppe P.; Soergel F., 1988: Pharmacokinetics of pefloxacin in normal and impaired renal function

Galtier, M.; Caron, J.; Bres, J.; Hansel, S.; Dubois, A., 1987: Pharmacokinetics of pefloxacin in plasma and saliva

Montay G.; Jacquot C.; Bariety J.; Cunci R., 1985: Pharmacokinetics of pefloxacin in renal insufficiency

Bernard N.; Cuisinaud G.; Pozet N.; Zech P.Y.; Sassard J., 1985: Pharmacokinetics of penbutolol and its metabolites in renal insufficiency

Haustein K O.; Wesser M., 1988: Pharmacokinetics of pengitoxin and its therapeutic efficacy in congestive heart failure

Welch W.D.; Lu Y S.; Bawdon R.E., 1987: Pharmacokinetics of penicillin g in serum and nasal washings of pasteurella multocida free and infected rabbits

Uhl S.; Schmid P.; Schlatter C., 1986: Pharmacokinetics of pentachlorophenol in man

Berman J.D.; Gallalee J.F.; Gallalee J.V., 1988: Pharmacokinetics of pentavalent antimony pentostam in hamsters

Cook C.E.; Seltzman T.B.; Tallent C.R.; Lorenzo B.; Drayer D.E., 1987: Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits

Fruncillo R.J.; Digregorio G.J., 1984: Pharmacokinetics of pentobarbital quinidine lidocaine and theophylline in the thermally injured rat

Rakhit A.; Kochak G.M.; Tipnis V.; Radensky P.; Hurley M.E.; Williams R., 1987: Pharmacokinetics of pentopril in the elderly

Guy R.H.; Hadgraft J., 1984: Pharmacokinetics of percutaneous absorption with concurrent metabolism

Favre R.; Charbit M.; Rinaldi Y.; Iliadis A.; Cano J.P.; Carcassonne Y., 1988: Pharmacokinetics of phase iv studies for dosage adjustment

Zherdev V.P.; Martynova L.A.; Kacha S.; Garattini S.; Ekonomov A.L., 1985: Pharmacokinetics of phenazepam and its metabolite 3 hydroxyphenazepam in different animals and humans

Karkishchenko N.N.; Khoron'ko V.V.; Lavrushko A.N.; Kuzam L.N., 1987: Pharmacokinetics of phenibut in pregnant women with late gestosis

Witte P.U.; Irmisch R.; Hajdu P., 1985: Pharmacokinetics of pheniramine avil and metabolites in healthy subjects after oral and intravenous administration

Syed, G. B.; Sharma, D. B.; Raina, R. K., 1986: Pharmacokinetics of phenobarbitone in protein energy malnutrition

Nomoto Y., 1986: Pharmacokinetics of phenol following phenol block

Hinchcliff K.W.; Mcguirk S.M.; Macwilliams P.S., 1987: Pharmacokinetics of phenolsulfonephthalein in horse and pony mares

Fischler M.; Levron J.C.; Trang H.; Vaxelaire J.F.; Flaiser B.; Vourc'h G., 1985: Pharmacokinetics of phenoperidine in anesthetized patients undergoing general surgery

Fischler M.; Levron J.C.; Trang H.; Brodaty D.; Dubois C.; Guilmet D.; Vourc'h G., 1985: Pharmacokinetics of phenoperidine in patients undergoing cardiopulmonary bypass

Soback S.; Kurtz B.; Ziv G., 1987: Pharmacokinetics of phenoxymethyl penicillin penicillin v in calves

Roos K.; Grahn E.; Ekedahl C.; Holm S.E., 1986: Pharmacokinetics of phenoxymethylpenicillin in tonsils

Streete J.M.; Berry D.J.; Newberry J.E.; Crome P., 1987: Pharmacokinetics of phenylethylmalonamide pema in elderly men

Dowse R.; Haigh J.M.; Kanfer I., 1987: Pharmacokinetics of phenylpropanolamine in humans after a single dose study

Lorenzi E.; Piacenza G.; Strumia E.; Borgoglio R., 1987: Pharmacokinetics of phosphocreatine and effect on blood levels of atp after intravenous administration in man

Hartvig P.; Wiklund L.; Lindstrom B., 1986: Pharmacokinetics of physostigmine after intravenous intramuscular and subcutaneous administration in surgical patients

Nolan R.J.; Freshour N.L.; Kastl P.E.; Saunders J.H., 1984: Pharmacokinetics of picloram in male volunteers

Sallee, F. R.; Pollock, B. G.; Stiller, R. L.; Stull, S.; Everett, G.; Perel, J. M., 1987: Pharmacokinetics of pimozide in adults and children with tourette's syndrome

Lau A.; Lee M.; Sharifi R., 1985: Pharmacokinetics of piperacillin in hospitalized patients

Charles D.; Larsen B., 1985: Pharmacokinetics of piperacillin in the postpartum patient

Blanc M.; Girard M.; Granier F.; Escande M.; Cotonat J., 1986: Pharmacokinetics of pipotiazine palmitate after intramuscular injection in schizophrenic patients

Tauber, U.; Weiss, C.; Krause, W.; Acksteiner, B.; Matthes, H., 1985: Pharmacokinetics of pirazolac a new anti inflammatory drug in human volunteers 1. absorption disposition biotransformation and excretion

Hayakawa A.; Misawa T.; Nishihara S.; Kobayashi S.; Bozler G., 1987: Pharmacokinetics of pirenzepine in patients with gastric or duodenal ulcers

Haegele, K. D.; Belz, G. G.; Meinicke, T. T.; Schechter, P. J., 1986: Pharmacokinetics of piroximone mdl 19205 in healthy volunteers

Rooney L.; Kendall M.J.; Main A.; Hosie J.; John V.A., 1985: Pharmacokinetics of pirprofen in young volunteers and elderly patients

Yamamoto I.; Iwata K.; Nakashima M., 1985: Pharmacokinetics of plasma and urine clenbuterol in man rat and rabbit

Tse F.L.S.; Jaffe J.M., 1987: Pharmacokinetics of pn 200 110 isradipine a new calcium antagonist after oral administration in man

Takenaka S.; Takahashi K.; Masuda Y., 1986: Pharmacokinetics of polychlorinated quaterphenyl congeners in rats after an oral dose

Toner J.M.; Ramsay L.E., 1985: Pharmacokinetics of potassium chloride in wax based and syrup formulations

Green M.D.; Talbot B.G.; Clark C.R., 1986: Pharmacokinetics of pralidoxime chloride in the rat

Derendorf H.; Rohdewald P.; Moellmann H.; Rehder J.; Barth J.; Neveling D., 1985: Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate

Goshima, E.; Yasuda, K.; Fuwa, Y.; Adachi, K.; Minamori, Y.; Murase, H.; Murayama, M.; Yamakita, N.; Miura, K., 1986: Pharmacokinetics of prednisolone during prednisolone treatment i. prednisolone pharmacokinetics during daily prednisolone treatment

Baron S.; Demay M.C.R.; Vasmant D.; Bensman A., 1988: Pharmacokinetics of prednisolone in children a search for correlation with tolerance and therapeutic effectiveness in nephrotic syndrome

Demotes-Mainard, F.; Potaux, L.; Aparicio, M.; De-Precigout, V.; Vincon, G.; Albin, H., 1986: Pharmacokinetics of prednisolone in kidney transplant patients with or without cushing's syndrome

Goshima, E.; Yasuda, K.; Fuwa, Y.; Adachi, K.; Minamori, Y.; Murase, H.; Murayama, M.; Yamakita, N.; Miura, K., 1987: Pharmacokinetics of prednisolone psl during psl treatment ii. psl pharmacokinetics during intermittent treatment with psl administration on 4 consecutive days a week

Unadkat J.D.; Rowland M., 1985: Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit

Bryla P.; Szumilo T., 1986: Pharmacokinetics of prethcamide following rapid intravenous injection and oral administration in rabbits

Bhatia S.C.; Saraph Y.S.; Revankar S.N.; Doshi K.J.; Bharucha E.D.; Desai N.D.; Vaidya A.B.; Subrahmanyam D.; Gupta K.C.; Satoskar R.S., 1986: Pharmacokinetics of primaquine in patients with plasmodium vivax malaria

Prasad R.N.; Garg S.K.; Mahajan R.C.; Ganguly N.K., 1985: Pharmacokinetics of primaquine in rhesus monkeys

Heeg J.F.; Hiser M.F.; Satonin D.K.; Rose J.Q., 1984: Pharmacokinetics of probucol in male rats

Sica D.A.; Yonce C.; Small R.; Cefali E.; Harford A.; Poynor W., 1988: Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis

Kirkpatrick T.; Cockshott I.D.; Douglas E.J.; Nimmo W.S., 1988: Pharmacokinetics of propofol diprivan in elderly patients

Cockshott I.D.; Briggs L.P.; Douglas E.J.; White M., 1987: Pharmacokinetics of propofol in female patients studies using single bolus injections

Katrukha S.P.; Kalenikova E.I.; Shcherbakov O.S.; Arzamastsev A.P.; Kukes V.G., 1984: Pharmacokinetics of propranolol

O'hare M.F.; Kinney C.D.; Murnaghan G.A.; Mcdevitt D.G., 1984: Pharmacokinetics of propranolol during pregnancy

Yu D.K.; Elmquist W.F.; Sawchuk R.J., 1985: Pharmacokinetics of propylene glycol in humans during multiple dosing regimens

Yu D.K.; Sawchuk R.J., 1987: Pharmacokinetics of propylene glycol in the rabbit

Hoffman, W. H.; Miceli, J. N., 1988: Pharmacokinetics of propylthiouracil in children and adolescents with graves' disease in the hyperthyroid and euthyroid states

Krause W.; Huempel M., 1988: Pharmacokinetics of proterguride in rat and cynomolgus monkey

Pannuti F.; Coppi G.; Borella F.; Martoni A.; Urbano L.; Melotti B., 1988: Pharmacokinetics of ptt 119 in man

Wong C.L.; Chan K.; Woo J.; Teoh R., 1987: Pharmacokinetics of pyrazinamide in csf and plasma of rabbits influence of anesthesia

Mckee M.J.; Knowles C.O., 1985: Pharmacokinetics of pyrethroids in two spotted spider mites tetranychus urticae

Feng Z.; Jiang N X.; Wang C Y.; Zhang W., 1986: Pharmacokinetics of pyronaridine an antimalarial in rabbits

Feng Z.; Wu Z F.; Wang C Y.; Jiang N X., 1987: Pharmacokinetics of pyronaridine in malaria patients

Shann F.; Stace J.; Edstein M., 1985: Pharmacokinetics of quinine in children

Bourgeois B.F.D.; Kuepfer A.; Wad N.; Egli M., 1986: Pharmacokinetics of r enantiomeric normephenytoin during chronic administration in epileptic patients

Wu D F.; Yu Y W.; Tang Z M.; Wang M Z., 1986: Pharmacokinetics of racemic and dextro and levo gossypol in humans and dogs

Hayes, D. F.; Zalutsky, M. R.; Kaplan, W.; Noska, M.; Thor, A.; Colcher, D.; Kufe, D. W., 1986: Pharmacokinetics of radiolabeled monoclonal antibody b 6.2 in patients with metastatic breast cancer

Garg D.C.; Baltodano N.; Perez G.O.; Oster J.R.; Jallad N.S.; Weidler D.J., 1985: Pharmacokinetics of ranitidine after intravenous administration in hemodialysis patients

Garg D.C.; Eshelman F.N.; Weidler D.J., 1985: Pharmacokinetics of ranitidine following oral administration with ascending doses and with multiple fixed doses

Varoquaux O.; Trawale J.M.; Doll J.; Andrieu J.; Grosbuis S.; Pays M.; Advenier C., 1985: Pharmacokinetics of ranitidine in acute upper gastrointestinal hemorrhage

Kopitar Z.; Cvelbar P.; Zorz M.; Milutinovic S.; Jankovic N., 1987: Pharmacokinetics of ranitidine in adult patients with end stage renal disease after single and multiple dosing

Ilett K.F.; Nation R.L.; Tjokrosetio R.; Thompson W.R.; Oh T.E.; Cameron P.D., 1986: Pharmacokinetics of ranitidine in critically ill patients

Reymann J.M.; Richard M.O.; Bretagne J.F.; Allain H.; Bentue Ferrer D.; D'athis P.; Van Den Driessche J., 1986: Pharmacokinetics of ranitidine in liver cirrhotic patients influence of ascites

Cavagna R.; Tessarin C.; Cerutti M.; Casol D.; Cielo R., 1987: Pharmacokinetics of ranitidine in patients on continuous ambulatory peritoneal dialysis

Garg D.C.; Baltodano N.; Jallad N.S.; Perez G.; Oster J.R.; Eshelman F.N.; Weidler D.J., 1986: Pharmacokinetics of ranitidine in patients with renal failure

Ferraiolo B.L.; Fuller G.B.; Burnett B.; Chan E., 1988: Pharmacokinetics of recombinant human interferon gamma in the rhesus monkey after intravenous intramuscular and subcutaneous administration

Maleci A.; Antonelli G.; Guidetti B.; Dianzani F., 1987: Pharmacokinetics of recombinant interferon alpha 2 following intralesional administration in malignant glioma patients

Minagawa K.; Miura H.; Mizuno S.; Shirai H., 1986: Pharmacokinetics of rectal diazepam in the prevention of recurrent febrile convulsions

Gilbert B.E.; Wyde P.R., 1988: Pharmacokinetics of ribavirin aerosol in mice

Ziya A.V.; Sokolova G.B.; Firsov A.A., 1987: Pharmacokinetics of rifampicin after its intravenous administration to patients with pulmonary tuberculosis

Koup, J. R.; Williams-Warren, J.; Weber, A.; Smith, A. L., 1986: Pharmacokinetics of rifampin in children i. multiple dose intravenous infusion

Koup, J. R.; Williams-Warren, J.; Viswanathan, C. T.; Weber, A.; Smith, A. L., 1986: Pharmacokinetics of rifampin in children ii. oral bioavailability

Krishna D.R.; Appa Rao A.V.N.; Ramanakar T.V.; Prabhakar M.C.; Narashimha Reddy K., 1984: Pharmacokinetics of rifampin in the presence of prednisolone in leprosy patients

Assandri A.; Ratti B.; Cristina T., 1984: Pharmacokinetics of rifapentine a new long lasting rifamycin in the rat mouse and rabbit

Krause W.; Kuehne G., 1988: Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys the rat and the rabbit studies on species differences

Gessler N.N.; Bezzubov A.A., 1987: Pharmacokinetics of s methylmethionine vitamin u in rats and man

Spahn H.; Langguth P.; Kirch W.; Mutschler E.; Ohnhaus E.E., 1986: Pharmacokinetics of salicylates administered with metoprolol

Kita Y.; Itakura K.; Tsuchiya K.; Imada A., 1986: Pharmacokinetics of sce 1141 a stereoisomer of cefmenoxime in rats

Massarella J.W.; Silvestri T.M.; Keigher N.; Pao J.; Dunton A., 1987: Pharmacokinetics of single and multiple ascending doses of the antiallergic tiacrilast in man

Kanarkowski R.; Tornatore K.M.; D'ambrosio R.; Gardner M.J.; Jusko W.J., 1988: Pharmacokinetics of single and multiple doses of ethynylestradiol and levonorgestrel in relation to smoking

Gillies H.C.; Rogers H.J.; Francis R.J.; Galloway D.B.; Humphreys J.E., 1986: Pharmacokinetics of single and multiple doses of flusoxolol ro 31 1411 in healthy subjects

Stump D.C.; Kieckens L.; De Cock F.; Collen D., 1987: Pharmacokinetics of single chain forms of urokinase type plasminogen activator

Silverman S.H.; Johnson M.; Burdon D.W.; Keighley M.R.B., 1986: Pharmacokinetics of single dose intravenous ciprofloxacin in patients undergoing gastrointestinal surgery

Aitkenhead A.R.; Vater M.; Achola K.; Cooper C.M.S.; Smith G., 1984: Pharmacokinetics of single dose intravenous morphine in normal volunteers and patients with end stage renal failure

Whitby M.; Edwards R.; Aston E.; Finch R.G., 1987: Pharmacokinetics of single dose intravenous vancomycin in capd peritonitis

Shalit I.; Greenwood R.B.; Marks M.I.; Pederson J.A.; Frederick D.L., 1986: Pharmacokinetics of single dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis

Gordin A.; Pohto P.; Sundberg S.; Nykanen S.; Haataja H.; Mannisto P., 1986: Pharmacokinetics of slow release diltiazem and its effect on atrioventricular conduction in healthy volunteers

Thomas D.E.; Beadle R.E., 1985: Pharmacokinetics of small doses of 3 methylindole given to horses

Moiseenok, A. G.; Dorofeev, B. F.; Kholodov, L. E.; Yakovleva, G. M., 1988: Pharmacokinetics of sodium 4' phosphopantothenate

Carli S.; Montesissa C.; Sozogni O.; Madonna M., 1986: Pharmacokinetics of sodium cefoperazone in calves

Kojima K.; Yamamoto K.; Fujioka H.; Kaneko H., 1985: Pharmacokinetics of spironolactone and potassium canrenoate in humans

Bolme P.; Eriksson M.; Habte D.; Paalzow L., 1988: Pharmacokinetics of streptomycin in ethiopian children with tuberculosis and of different nutritional status

Ladygina G.A.; Vladimirskii M.A.; Firsov A.A.; Tentsova A.I., 1984: Pharmacokinetics of streptomycin in mice after the administration of its liposomal form

Davis P.J.; Stiller R.L.; Cook D.R.; Brandom B.W.; Davin Robinson K.A., 1988: Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure

Fyman P.N.; Reynolds J.R.; Moser F.; Avitable M.; Casthely P.A.; Butt K., 1988: Pharmacokinetics of sufentanil in patients undergoing renal transplantation

Barron M.G.; Gedutis C.; James M.O., 1988: Pharmacokinetics of sulfadimethoxine in the lobster homarus americanus following intrapericardial administration

Jha H.N.; Bal M.S.; Paul B.S., 1987: Pharmacokinetics of sulfadimidine in buffalo calves

Edstein M.D., 1987: Pharmacokinetics of sulfadoxine and pyrimethamine after fansidar administration in man

Bobrov V.I.; Nazarova O.I.; Agapitova I.V.; Kalenik N.M.; Yakovlev V.P., 1984: Pharmacokinetics of sulfalene and sulfadimethoxine combinations with benzylpenicillin and ampicillin

Bobrov V.I.; Briker V.A.; Glezer G.A.; Yakovlev V.P., 1987: Pharmacokinetics of sulfalene and sulfadimethoxine in patients with chronic pyelonephritis

Duffee N.E.; Bevill R.F.; Thurmon J.C.; Luther H.G.Jr; Nelson D.E.; Hacker F.E., 1984: Pharmacokinetics of sulfamethazine in male female and castrated male swine

Baakman M.; Nouws J.F.M.; Vree T.B., 1987: Pharmacokinetics of sulfanilamide and its three acetyl metabolites in dairy cows and calves

Schlicht F.; Staiger C.; De Vries J.; Gundert Remy U.; Hildebrandt R.; Harenberg J.; Wang N.S.; Weber E., 1985: Pharmacokinetics of sulfinpyrazone and its major metabolites after a single dose and during chronic treatment

Oie S., 1985: Pharmacokinetics of sulfisoxazole in rabbits with experimental renal failure after single and multiple dosing

Shermantine M.; Gambertoglio J.; Amend W.; Vincenti F.; Oie S., 1985: Pharmacokinetics of sulfisoxazole in renal transplant patients

Kassem M.A.; El Ridy M.S.; Khairy L.M., 1987: Pharmacokinetics of sulfisoxazole solid dispersions in rabbits

Tufenkji A.E.; Alvinerie M.; Houin G.; Galtier P., 1987: Pharmacokinetics of sulfobromophthalein lidocaine and indocyanine green in the course of subclinical fascioliasis in sheep

Tyler J.L.; Yamamoto Y.L.; Diksic M.; Theron J.; Villemure J.G.; Worthington C.; Evans A.C.; Feindel W., 1986: Pharmacokinetics of superselective intra arterial and intravenous carbon 11 1 3 bis 2 chloroethyl 1 nitrosourea evaluated by positron emission tomography

Mattila J.; Mantyla R.; Taskinen J.; Mannisto P., 1985: Pharmacokinetics of sustained release verapamil after a single administration and at steady state

Ohashi M.; Fujio N.; Nawata H.; Kato K I.; Matsuo H.; Ibayashi H., 1987: Pharmacokinetics of synthetic alpha human atrial natriuretic polypeptide in normal men effect of aging

Kent G.N.; Loveridge N.; Reeve J.; Zanelli J.M., 1985: Pharmacokinetics of synthetic human parathyroid hormone 1 34 in man measured by cytochemical bioassay and radioimmunoassay

Benuck M.; Lajtha A.; Reith M.E., 1987: Pharmacokinetics of systemically administered cocaine and locomotor stimulation in mice

Sintov A.; Bialer M.; Yagen B., 1987: Pharmacokinetics of t 2 tetraol a urinary metabolite of the trichothecene mycotoxin t 2 toxin in dog

Sintov A.; Bialer M.; Yagen B., 1986: Pharmacokinetics of t 2 toxin and its metabolite ht 2 toxin after intravenous administration in dogs

Jamali F.; Russell A.S.; Lehmann C.; Berry B.W., 1985: Pharmacokinetics of taiprofenic acid in healthy and arthritic subjects

Ovdienko N.I.; Starovoitova L.P.; Kodina G.E.; Malysheva A.O.; Tul'skaya T.I., 1987: Pharmacokinetics of technetium 99m labeled technefit in the radionuclide investigations of the liver and kidneys

Zimmer A.M.; Kazikiewicz J.M.; Rosen S.T.; Spies S.M., 1987: Pharmacokinetics of technetium 99m tin and iodine 131 labeled anti carcinoembryonic antigen monoclonal antibody fragments in nude mice

Ripa S.; Ferrante L.; Mignini F.; Falcioni E., 1988: Pharmacokinetics of teicoplanin

Domart Y.; Pierre C.; Clair B.; Garaud J.J.; Regnier B.; Gibert C., 1987: Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment

Traina G.L.; Bonati M., 1984: Pharmacokinetics of teicoplanin in man after intravenous administration

Traina G.L.; Gentile M.G.; Fellin G.; Rosina R.; Cavenaghi L.; Buniva G.; Bonati M., 1986: Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis

Terragna A.; Ferrea G.; Loy A.; Danese A.; Bernareggi A.; Cavenaghi L.; Rosina R., 1988: Pharmacokinetics of teicoplanin in pediatric patients

Falcoz C.; Ferry N.; Pozet N.; Cuisinaud G.; Zech P.Y.; Sassard J., 1987: Pharmacokinetics of teicoplanin in renal failure

Mueller F.O.; Van Dyk M.; Hundt H.K.L.; Joubert A.L.; Luus H.G.; Groenewoud G.; Dunbar G.C., 1987: Pharmacokinetics of temazepam after day time and night time oral administration

Klem K.; Murray G.R.; Laake K., 1986: Pharmacokinetics of temazepam in geriatric patients

D'incalci M.; Rossi C.; Sessa C.; Urso R.; Zucchetti M.; Farina P.; Mangioni C., 1985: Pharmacokinetics of teniposide in patients with ovarian cancer

Francis R.J.; Allen J.G.; Looi D.; Dixon J.S.; Bird H.A.; Wright V., 1987: Pharmacokinetics of tenoxicam after oral administration in healthy human subjects of various single doses

Horber F.F.; Guentert T.W.; Weidekamm E.; Heizmann P.; Descoeudres C.; Frey F.J., 1986: Pharmacokinetics of tenoxicam in patients with impaired renal function

Lyrenas S.; Grahnen A.; Lindberg B.; Lindstrom B.; Lonnerholm G., 1986: Pharmacokinetics of terbutaline during pregnancy

Mehvar R.; Jamali F.; Watson M.W.B.; Skelton D., 1987: Pharmacokinetics of tetrabenazine and its major metabolite in man and rat bioavailability and dose dependency studies

Ward R.C.; Travis C.C.; Hetrick D.M.; Andersen M.E.; Gargas M.L., 1988: Pharmacokinetics of tetrachloroethylene

Percy D.H.; Black W.D., 1988: Pharmacokinetics of tetracycline in the domestic rabbit following intravenous or oral administration

Krahwinkel W.; Herzog H.; Feinendegen L.E., 1988: Pharmacokinetics of thallium 201 in normal individuals after routine myocardial scintigraphy

Martens M.G.; Faro S.; Feldman S.; Cotton D.B.; Dorman K.; Riddle G.D., 1987: Pharmacokinetics of the acylureidopenicillins piperacillin and mezlocillin in the postpartum patient

Martens M.G.; Faro S.; Feldman S.; Cotton D.B.; Dorman K.; Riddle G.D., 1987: Pharmacokinetics of the advanced generation cephalosporins in the postpartum patient

Pisani F.; Fazio A.; Spina E.; Artesi C.; Pisani B.; Russo M.; Trio R.; Perucca E., 1986: Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment

Kholodov L.E.; Revazova Yu A.; Tishchenkova I.F.; Radchenko L.U., 1983: Pharmacokinetics of the antitumor preparation fotrin and its medicinal form with polyvinylpyrrolidone in mice

Chasseaud L.F.; Wood S.G., 1986: Pharmacokinetics of the bronchodilator tulobuterol in man after repeated oral doses

Francis R.J.; Brown A.N.; Kler L.; Fasanella D'amore T.; Nussberger J.; Waeber B.; Brunner H.R., 1987: Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition development of a mathematical model

Tamassia V.; Jannuzzo M.G.; Moro E.; Stegnjaich S.; Groppi W.; Nicolis F.B., 1984: Pharmacokinetics of the enantiomers of indoprofen in man

Singh N.N.; Jamali F.; Pasutto F.M.; Russell A.S.; Coutts R.T.; Drader K.S., 1986: Pharmacokinetics of the enantiomers of tiaprofenic acid in humans

Walter U.; Roeckel A.; Lahn W.; Heidland A.; Heptner W., 1985: Pharmacokinetics of the loop diuretic piretanide in renal failure

Brown, B. A.; Comeau, R. D.; Jones, P. L.; Liberatore, F. A.; Neacy, W. P.; Sands, H.; Gallagher, B. M., 1987: Pharmacokinetics of the monoclonal antibody b72.3 and its fragments labeled with either iodine 125 or indium 111

Filser J.G.; Peter H.; Bolt H.M.; Fedtke N., 1987: Pharmacokinetics of the neurotoxin n hexane in rat and man

Roncari G.; Ziegler W.H.; Guentert T.W., 1986: Pharmacokinetics of the new benzodiazepine antagonist ro 15 1788 in man following intravenous and oral administration

Scasnar V.; Kallay Z.; Bezk S.; Trnovec T.; Durisova M., 1987: Pharmacokinetics of the new local anesthetic n 2 2 heptyloxyphenylcarbamoyloxyethylpiperidinium chloride in rats and mice

Forgue S.T.; Shyu W.C.; Gleason C.R.; Pittman K.A.; Barbhaiya R.H., 1987: Pharmacokinetics of the novel cephalosporin cefepine bmy 28142 in rats and monkeys

Meijer D.K.F.; Hovinga G.; Versluis A.; Broring J.; Van Aken K.; Moolenaar F.; Wesseling H., 1984: Pharmacokinetics of the oral narcotic analgesic bezitramide and preliminary observations on its effect on experimentally induced pain

Wingen F.; Schmaehl D., 1987: Pharmacokinetics of the osteotropic diphosphonate 3 amino 1 hydroxypropane 1 1 diphosphonic acid in mammals

Zimmerman C.L.; Franz T.J.; Slattery J.T., 1984: Pharmacokinetics of the poly gamma glutamyl metabolites of methotrexate in skin and other tissues of rats and hairless mice

Wang G.; Aedo A R.; Cekan S.Z., 1986: Pharmacokinetics of the progesterone antagonist 17 beta hydroxy 11 beta 4 dimethylaminophenyl 17 alpha 1 propynyl estra 4 9 dien 3 one in the rabbit

Newell D.R.; Alison D.L.; Calvert A.H.; Harrap K.R.; Jarman M.; Jones T.R.; Manteuffel Cymborowska M.; O'connor P., 1986: Pharmacokinetics of the thymidylate synthase inhibitor n 10 propargyl 5 8 dideazafolic acid cb 3717 in the mouse

Lauterburg B.H.; Smith C.V.; Todd E.L.; Mitchell J.R., 1985: Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans

Beasley V.R.; Swanson S.P.; Corley R.A.; Buck W.B.; Koritz G.D.; Burmeister H.R., 1986: Pharmacokinetics of the trichothecene mycotoxin t 2 toxin in swine and cattle

Varoquaux O.; Lajoie D.; Gobert C.; Cordonnier P.; Ducreuzet C.; Pays M.; Advenier C., 1985: Pharmacokinetics of the trimethoprim sulfamethoxazole combination in the elderly

Ito M.; Aizawa K.; Komiya I.; Miyagi K.; Fujita M.; Umemura K., 1986: Pharmacokinetics of the two major metabolites of ethyl loflazepate cm 6912 in dogs and humans simulation by a digital computer

Traina G.L.; Bonati M., 1985: Pharmacokinetics of theobromine and its metabolites in rabbits

Bortolotti A.; Bonati M., 1985: Pharmacokinetics of theobromine in male rats in different traumatic conditions

Laursen L.C.; Johannesson N.; Weeke B., 1985: Pharmacokinetics of theophylline and enprofylline in patients requiring a high or low dose of theophylline

Celardo A.; Traina G.L.; Jankowski A.; Bonati M., 1985: Pharmacokinetics of theophylline and its metabolites in rabbits

Hasegawa T.; Ogura Y.; Takeshi K.; Mizukami Y., 1984: Pharmacokinetics of theophylline in asthmatic children after multiple oral doses of aminophylline tablets

Nosaka H.; Takagi K.; Hasegawa T.; Ogura Y.; Mizukami Y.; Satake T., 1986: Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained release theophylline tablet formulation

Lin F.J.; Kuo H T.; Huang W C.; Lee C M.; Lin C C., 1987: Pharmacokinetics of theophylline in chinese asthmatics

Pokrajac M.; Simic D.; Varagic V.M., 1987: Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease

Stile I.L.; Zolfaghari S.; Hiatt I.M.; Hegyi T., 1986: Pharmacokinetics of theophylline in premature infants on the first day of life

Jung D., 1985: Pharmacokinetics of theophylline in protein calorie malnutrition

Garg D.C.; Goldberg R.N.; Woo Ming R.B.; Weidler D.J., 1988: Pharmacokinetics of thiopental in the asphyxiated neonate

Monrigal C.; Premel Cabic A.; Turcant A.; Bourgeonneau M.C.; Cavellat M.; Allain P., 1986: Pharmacokinetics of thiopentone in women and neonates

Watson A.D.J.; Van Gogh H.; Van Deurzen E.J.M.; Van Duin C.T.M.; Van Miert A.S.J.P.A.M., 1987: Pharmacokinetics of three sulfonamides in ruminant and preruminant kids

Rousselet F.; Clenet M.; Gueris J., 1986: Pharmacokinetics of tiadenol in the rat

Gonzalez Lopez F.; Marino E.L.; Dominguez Gil A., 1986: Pharmacokinetics of tiadipone a new anxiolytic

Roos, R. A. C.; De-Haas, E. J. M.; Buruma, O. J. S.; De-Wolff, F. A., 1986: Pharmacokinetics of tiapride in patients with tardive dyskinesia and huntington's disease

Obeng E.K.; Vallner J.J.; Cadwallader D.E.; Tackett R.L., 1987: Pharmacokinetics of tiazofurin in dogs

Grygiel J.J.; Balis F.M.; Collins J.M.; Lester C.M.; Poplack D.G., 1985: Pharmacokinetics of tiazofurin in the plasma and cerebrospinal fluid of rhesus monkeys

Jungbluth G.J.; Cooper D.L.; Doyle G.D.; Chudzik G.M.; Jusko W.J., 1986: Pharmacokinetics of ticarcillin and clavulanic acid timentin in relation to renal function

Arigoni R.; Chiste R.; Drovanti A.; Makovec F.; Senin P.; Setnikar I., 1986: Pharmacokinetics of tiropramide after single doses in man

Adams J.D.; Lavoie E.J.; Hoffmann D., 1985: Pharmacokinetics of tobacco specific n nitrosamines in fischer rats

King C.H.; Creger R.J.; Ellner J.J., 1985: Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs

Horrevorts A.M.; Degener J.E.; Dzoljic Danilovic G.; Michel M.F.; Kerrebijn K.F.; Driessen O.; Hermans J., 1985: Pharmacokinetics of tobramycin in patients with cystic fibrosis implications for the dosing interval

Braun J.; Sorgel F.; Engelmaier F.; Gluth W.P.; Gessler U., 1985: Pharmacokinetics of tocainide in patients with severe renal failure

Pentikainen P.J.; Tokola O.; Alhava E.; Penttila A., 1984: Pharmacokinetics of tolfenamic acid disposition in bile blood and urine after intravenous administration in man

Stenderup J.; Eriksen J.; Bols Pedersen S.; Christiansen L.V., 1985: Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver

Wiederholt M.; Koessendrup D.; Schulz W.; Hoffmann F., 1986: Pharmacokinetics of topical cyclosporin a in the rabbit eye

Connor M.J.; Lindae M.L.; Lowe N.J., 1985: Pharmacokinetics of topically applied radiolabeled retinoids in hairless mouse epidermis and dermis after single applications

Berner B., 1985: Pharmacokinetics of transdermal drug delivery

Mollmann H.; Rohdewald P.; Schmidt E.W.; Salomon V.; Derendorf H., 1985: Pharmacokinetics of triamcinolone acetonide and its phosphate ester

Burke R.E.; Fahn S., 1985: Pharmacokinetics of trihexyphenidyl after short term and long term administration to dystonic patients

Van Kalken C.K.; Van Der Meulen J.; Oe P.L.; Vriesendorp R.; Donker A.J.M., 1986: Pharmacokinetics of trimazosin and its effects on blood pressure renal function and proteinuria during short term therapy of patients with impaired renal function and hypertension

Dudley M.N.; Levitz R.E.; Quintiliani R.; Hickingbotham J.M.; Nightingale C.H., 1984: Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges

Shoaf S.E.; Schwark W.S.; Guard C.L.; Schwartsman R.V., 1986: Pharmacokinetics of trimethoprim sulfadiazine in neonatal calves influence of synovitis

Reece P.A.; Morris R.G.; Bishop J.F.; Olver I.N.; Raghavan D., 1987: Pharmacokinetics of trimetrexate administered by five day continuous infusion to patients with advanced cancer

Balis F.M.; Lester C.M.; Poplack D.G., 1986: Pharmacokinetics of trimetrexate nsc 352122 in monkeys

Shimanovskii N.L.; Rozenberg O.A.; Mikhailova N.Ya; Loshakova L.V.; Pukhal'skaya T.G.; Khanson K.P.; Sergeev P.V., 1987: Pharmacokinetics of triombrast encapsulated in liposomes

Ritschel W.A.; Grummich K.W.; Hussain S.A., 1985: Pharmacokinetics of trisodium phosphonoformate after intravenous and oral administration to beagle dogs and rabbits

Shum L.; Jusko W.J., 1986: Pharmacokinetics of tritiated water in normal and dietary induced obese rats

Shapiro W.R.; Voorhies R.M.; Hiesiger E.M.; Sher P.B.; Basler G.A.; Lipschutz L.E., 1988: Pharmacokinetics of tumor cell exposure to carbon 14 methotrexate after intracarotid administration without and with hyperosmotic opening of the blood brain and blood tumor barriers in rat brain tumors a quantitative autoradiographic study

Fulton R.J.; Tucker T.F.; Vitetta E.S.; Uhr J.W., 1988: Pharmacokinetics of tumor reactive immunotoxins in tumor bearing mice effect of antibody valency and deglycosylation of the ricin a chain on clearance and tumor localization

Janicke D.M.; Parker S.W.; Cafarell R.F.; Apicella M.A.; Jusko W.J., 1988: Pharmacokinetics of two multiple dose mezlocillin regimens

Benvenuti C.; Cancellieri V.; Gambaro V.; Lodi F.; Marozzi E.; Scaroni C., 1986: Pharmacokinetics of two new oral formulations of ibuprofen

Kanamoto I.; Nakagawa T.; Horikoshi I.; Koizumi T.; Tazawa K.; Fujimaki M., 1988: Pharmacokinetics of two rectal dosage forms of ketoprofen in patients after anal surgery

Takabatake T.; Ohta H.; Yamamoto Y.; Ishida Y.; Hara H.; Nakamura S.; Ushiogi Y.; Satoh S.; Hattori N., 1986: Pharmacokinetics of tzu 0460 a new h 2 receptor antagonist in patients with impaired renal function

Reece P.A.; Bishop J.F.; Olver I.N.; Stafford I.; Hillcoat B.L.; Morstyn G., 1987: Pharmacokinetics of unchanged carboplatin cbdca in patients with small cell lung carcinoma

Mazoit J X.; Sandouk P.; Zetlaoui P.; Scherrmann J M., 1987: Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects

Noda T.; Kamamoto Y.; Saitoh S.; Nakanishi A.; Ando Y.; Tsuji Y.; Yoh S.; Moriyama I.; Ichijo M., 1984: Pharmacokinetics of vaginal suppository ft 207 ftorafur on uterine cervical cancer and radiation therapy

Alos Alminana M.; Calduch Alvarez M.L.; Ezquer Borras J.; Canto Pascual M.; Guevara Serrano J., 1987: Pharmacokinetics of valproic acid in monotherapy and polytherapy

Bialer M.; Hussein Z.; Raz I.; Abramsky O.; Herishanu Y.; Pachys F., 1985: Pharmacokinetics of valproic acid in volunteers after a single dose study

Daschner F.D.; Frank U.; Kuemmel A.; Schmidt Eisenlohr E.; Schlosser V.; Spillner H.; Schuster B.; Schindler M., 1987: Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open heart surgery

Amla V.; Bano G.; Johri R.K.; Zutshi U.; Atal C.K., 1987: Pharmacokinetics of vasicine in healthy indian volunteers

Staneva D.; Mihailova D.; Astroug H.; Prodanova K.; Micheva M., 1988: Pharmacokinetics of vephylline a new n substituted theophylline derivative

Staveris S.; Plusquellec Y.; Campistron G.; Barre J.; Rochas M.A.; Jung L.; Tillement J.P.; Koffell J.C.; Houin G., 1988: Pharmacokinetics of veralipride after chronic administration in humans

Rumyantsev D.O.; Piotrovskii V.K.; Metelitsa V.I.; Ryabokon' O.S.; Kokurina E.V.; Slastnikova I.D.; Bochkareva E.B.; Urumbaev R.K., 1988: Pharmacokinetics of verapamil and its n dealkylated metabolites in patients with chronic ischemic heart disease under long term monotherapy

Jorgensen N.P.; Walstad R.A., 1988: Pharmacokinetics of verapamil and norverapamil in patients with hypertension a comparison of oral conventional and sustained release formulations

Anderson, P.; Bondesson, U.; Faire, U. D., 1986: Pharmacokinetics of verapamil in patients with hypertension

Mooy J.; Schols M.; Baak M.V.; Hooff M.V.; Muytjens A.; Rahn K.H., 1985: Pharmacokinetics of verapamil in patients with renal failure

Van Gulpen C.; Kelder O.; Mattie H.; Van Der Meer J.W.M.; Van't Wout J., 1985: Pharmacokinetics of vibunazole bay n 7133 administered orally to healthy subjects

Sethi V.S.; Surratt P.; Spurr C.L., 1984: Pharmacokinetics of vincristine vinblastine and vindesine in rhesus monkeys macaca mulatta

Jackson D.V.Jr; Sethi V.S.; Long T.R.; Muss H.B.; Spurr C.L., 1984: Pharmacokinetics of vindesine bolus and infusion

Ohnuma T.; Norton L.; Andrejczuk A.; Holland J.F., 1985: Pharmacokinetics of vindesine given as an intravenous bolus and 24 hour infusion in humans

Sann L.; Leclercq M.; Frederich A.; Bourgeois J.; Bethenod M.; Bourgeay Causse M., 1985: Pharmacokinetics of vitamin k 1 in low birth weight neonates

Figoli F.; Zanette M.L.; Tirelli U.; Sorio R.; Lestuzzi C.; Urso R.; Monfardini S.; D'incalci M., 1987: Pharmacokinetics of vm 26 given intrapericardially or intravenously in patients with malignant pericardial effusion

Wilensky A.J.; Friel P.N.; Ojemann L.M.; Kupferberg H.J.; Levy R.H., 1985: Pharmacokinetics of w 554 add 03055 in epileptic patients

Ganeval D.; Fischer A.M.; Barre J.; Pertuiset N.; Dautzenberg M.D.; Jungers P.; Houin G., 1986: Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin k dependent clotting factors

Zherdev V.P.; Sariev A.K.; Dvoryaninov A.A.; Voronina T.A.; Smirnov L.D., 1986: Pharmacokinetics of water soluble antioxidant of 3 hydroxypyridine type

Sorensen E.V.; Faergeman O.; Day M.; Bastain W., 1988: Pharmacokinetics of xamoterol after intravenous and oral administration to patients with chronic heart failure

Bastain W.; Boyce M.J.; Stafford L.E.; Morton P.B.; Clarke D.A.; Marlow H.F., 1988: Pharmacokinetics of xamoterol after intravenous and oral administration to volunteers

Mulder G.J.; Groen K.; Tijdens R.B.; Meijer D.K.F., 1987: Pharmacokinetics of xamoterol glucuronidation in the rat in vivo and in liver perfusion

Dyer D.C.; Hsu W.H.; Lloyd W.E., 1987: Pharmacokinetics of xylazine in ponies influence of yohimbine

Gottfries C G.; Grind M.; Lundstrom J.; Alling C., 1986: Pharmacokinetics of zimeldine in male alcoholics

Grekas D.; Nikolaides P.; Alexiou P.; Tourkantonis A., 1988: Pharmacokinetics of zinc in chronic renal failure after intravenous administration

Grekas D.; Nicolaides P.; Tsakalos N.; Tourkantonis A., 1985: Pharmacokinetics of zinc in chronic renal failure patients

Migally N.B.; Fahim M.S., 1984: Pharmacokinetics of zinc tannate after intratesticular injection

Yee G.C.; Kennedy M.S.; Storb R.; Thomas E.D., 1984: Pharmacokinetics on intravenous cyclosporine in bone marrow transplant patients comparison of 2 assay methods

Zalanyi S.; Landgren B M.; Johannisson E., 1984: Pharmacokinetics pharmacodynamic and endometrial effects of a single dose of 200 milligrams of norethisterone enanthate

Wassef R.; Cohen Z.; Langer B., 1985: Pharmacokinetics profiles of cyclosporine in rats influence of route of administration and dosage

Nouws J.F.M.; Mevius D.J.; Vree T.B.; Baars A.M.; Laurensen J., 1988: Pharmacokinetics renal clearance and metabolism of ciprofloxacin following intravenous and oral administration to calves and pigs

Javed I.; Nawaz M.; Ahmed M.; Rehman Z.U.; Shah B.H., 1984: Pharmacokinetics renal clearance and urinary excretion of chloramphenicol in goats

Nouws J.F.M.; Vree T.B.; Baakman M.; Driessens F.; Vellenga L.; Mevius D.J., 1988: Pharmacokinetics renal clearance tissue distribution and residue aspects of sulfadimidine and its n 4 acetyl metabolite in pigs

Nouws J.F.M.; Vree T.B.; Holtkamp J.; Baakman M.; Driessens F.; Guelen P.J.M., 1986: Pharmacokinetics residue and irritation aspects of chloramphenicol sodium succinate and a chloramphenicol base formulation following intramuscular administration to ruminants

Ringden O.; Lonnqvist B.; Paulin T.; Ahlmen J.; Klintmalm G.; Wahren B.; Lernestedt J O., 1986: Pharmacokinetics safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

Kurzrock R.; Rosenblum M.G.; Sherwin S.A.; Rios A.; Talpaz M.; Quesada J.R.; Gutterman J.U., 1985: Pharmacokinetics single dose tolerance and biological activity of recombinant gamma interferon in cancer patients

Wu X.; Zhou B.; Jia Y.; Li T., 1988: Pharmacokinetics study of antiepileptic drug sc 1001 sodium in rabbits

Hersh M.R.; Kuhn J.G.; Phillips J.L.; Clark G.; Ludden T.M.; Von Hoff D.D., 1986: Pharmacokinetics study of fludarabine phosphate nsc 312887

Tamassia V.; Pacciarini M.A.; Moro E.; Piazza E.; Vago G.; Libretti A., 1987: Pharmacokinetics study of intravenous and oral idarubicin in cancer patients

Giri S.N., 1986: Pharmacokinetics subcellular distribution and covalent binding of tritiated bleomycin in hamsters after intratracheal administration

Labourel C.; Blanchart J.M., 1987: Pharmacokinetics what is an action duration example of ibt duphar antiinfective agents

Brady L.J.; Knoeber C.M.; Hoppel C.L.; Leathers C.W.; Mcfarland D.; Brady P.S., 1986: Pharmacologic action of l carnitine on hypertriglyceridemia in obese zucker rats

Lipkan G.N.; Maksyutina N.P.; Voitenko G.N.; Pogodina L.I., 1981: Pharmacologic action of poly phenols of robinia pseudoacacia racemes

Popov R.Ya; Gudasheva T.A.; Trofimov S.S.; Ostrovskaya R.U.; Skoldinov A.P., 1983: Pharmacologic activity of piracetam analogs and cyclo homologues

Greaves, M. W.; Sondergaard, J., 1970: Pharmacologic agents released in uv inflammation studied by continuous skin perfusion

Lee H B.; Wexler J.P.; Scharf S.C.; Blaufox M.D., 1983: Pharmacologic alterations in technetium 99m binding by red blood cells concise communication

Kusner E.J.; Knee C.D.; Krell R.D., 1987: Pharmacologic analysis of 1 o alkyl 2 acetyl sn glycero 3 phosphocholine induced increases in cutaneous vascular permeability in the rat

Fleisch J.H.; Haisch K.D.; Spaethe S.M.; Rinkema L.E.; Cullinan G.J.; Schmidt M.J.; Marshall W.S., 1984: Pharmacologic analysis of 2 novel inhibitors of leukotriene slow reacting substance release

Chiba, S., 1977: Pharmacologic analysis of chronotropic and inotropic responses to 5 hydroxy tryptamine in the dog heart

Saegusa K.; Furukawa Y.; Ogiwara Y.; Chiba S., 1986: Pharmacologic analysis of ketamine induced cardiac actions in isolated blood perfused canine atria

Fleisch J.H.; Rinkema L.E.; Haisch K.D.; Whitesitt C.A., 1987: Pharmacologic analysis of ly 188695 kb 2413 1 2 ethoxyethyl 2 4 methyl 1 homopiperazinylbenzimidazole difumarate a potent histamine 1 receptor antagonist

Myslobodsky M.S.; Morag M., 1981: Pharmacologic analysis of sodium valproate induced suppression of secondary components of visual evoked potentials in albino rats

Chiba, S., 1977: Pharmacologic analysis of stretch induced sinus acceleration of the isolated dog atrium

Culver, N. G.; Fischman, D. A., 1977: Pharmacologic analysis of sympathetic function in the embryonic chick heart

Holtzman, S. G.; Villarreal, J. E., 1971: Pharmacologic analysis of the hypo thermic responses of the morphine dependent rhesus monkey

Weiss G.R.; Gaskill H.V.IIi; Phillips J.L., 1986: Pharmacologic analysis of the intraperitoneal administration of fludarabine phosphate in the swine

Myslobodsky M.S.; Mintz M.; Kofman O., 1981: Pharmacologic analysis of the post ictal immobility syndrome in the rat

Skolnick, P.; Lock, K. L.; Paugh, B.; Marangos, P.; Windsor, R.; Paul, S., 1980: Pharmacologic and behavioral effects of emd 28422 n 6 2 4 chlorophenyl bi cyclo 2.2.2 octyl 3 adenosine a novel purine which enhances tritium labeled diazepam binding to brain benzodiazepine receptors

Blum, S. W.; Quinn, J. B.; Howe, B. B.; Hefner, M. A.; Winbury, M. M., 1971: Pharmacologic and biochemical evaluation of organic nitrates attempted correlation of activities

Eckels D.D.; Gershwin M.E., 1981: Pharmacologic and biochemical modulation of human t lymphocyte colony formation hormonal influences

Rafanell J.G.; Belles L.; Sanchez M.S.; Forn J., 1981: Pharmacologic and biochemical study of a new nonnarcotic analgesic fosfosal ur 1521

Carrasco M.S.; Nalda M.A.; Casais L.; Cuenca E., 1985: Pharmacologic and clinical study of a substance with possible neuroleptic action its use in anesthesia

Dilov P.; Dimitrov S.; Nikolov A.; Chaleva E.; Panchev I.; Ganovski D., 1984: Pharmacologic and clinico pharmacologic studies of diazepam pulvis in suspension

Malkinson A.M., 1984: Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation

Karliner, J. S.; Lewinter, M. M.; Mahler, F.; Engler, R.; O'rourke, R. A., 1977: Pharmacologic and hemodynamic influences on the rate of iso volumic left ventricular relaxation in the normal conscious dog

Sharkawi M.; Abdel Latif A.G., 1987: Pharmacologic and metabolic interactions between ethanol and promethazine

Wei X.Y.; Luchowski E.M.; Rutledge A.; Su C.M.; Triggle D.J., 1986: Pharmacologic and radioligand binding analysis of the actions of 1 4 dihydropyridine activator antagonist pairs in smooth muscle

Vaupel D.B.; Risner M.E.; Shannon H.E., 1986: Pharmacologic and reinforcing properties of phencyclidine and the enantiomers of n allylnormetazocine in the dog

Tealdi D.; Biasi G.; Trazzi R., 1980: Pharmacologic and surgical procedures for prevention of the re vascularization syndrome

Wasserman M.A., 1981: Pharmacologic and therapeutic implications of prostaglandins on airway smooth muscle

Hacker M.P.; Newman R.A.; Mccormack J.J.; Krakoff I.H., 1980: Pharmacologic and toxicologic evaluation of thio proline a proposed nontoxic inducer of reverse transformation

Simmons J.W.; Upman P.J.; Stavinoha W.B., 1984: Pharmacologic and toxicologic profile of chymopapain b chemolase

Veldkamp, W.; Rudzik, A. D., 1970: Pharmacologic and toxicologic studies with the mono potassium salt of acetylenedicarboxylic acid

Goyings, L. S.; Lauderdale, J. W.; Geng, S., 1978: Pharmacologic and toxicologic study of prostaglandin f 2 alpha in cattle

Goyings, L. S.; Lauderdale, J. W.; Geng, S.; Mcconnell, R. F., 1977: Pharmacologic and toxicologic study of prostaglandin f 2 alpha in mares

Spotnitz, H. M.; Avery, G. J-Ii ; Rose, E. A.; Benvenisty, A. I.; Malm, J. R.; Hoffman, B. F., 1980: Pharmacologic antagonism of beta adrenergic blockade in dogs 2. hemodynamic effects of simultaneous intra venous infusion of isoproterenol and dopamine during chronic propranolol administration

Avery G.J.; Spotnitz H.M.; Rose E.A.; Malm J.R.; Hoffman B.F., 1979: Pharmacologic antagonism of beta adrenergic blockade in dogs part 1 hemodynamic effects of isoproterenol dopamine and epinephrine in acute propranolol administration

Wei, J.; Spotnitz, H. M.; Spotnitz, W. D.; Benvenisty, A. I.; Haasler, G. B.; Malm, J. R.; Hoffman, B. F., 1984: Pharmacologic antagonism of propranolol in dogs 3. effects of dopamine isoproterenol and glucagon on hemodynamics and myo cardial oxygen consumption in ischemic hearts during chronic propranolol administration

Dorr R.T.; Alberts D.S., 1981: Pharmacologic antidotes to experimental doxorubicin skin toxicity a suggested role for beta adrenergic compounds

Myerburg R.J.; Kessler K.M.; Zaman L.; Fernandez P.; Demarchena E.; Castellanos A., 1987: Pharmacologic approaches to management of arrhythmias in patients with cardiomyopathy and heart failure

Kathol R.G.; Wilcox J.A.; Turner R.D.; Kronfol Z.; Olson S.C., 1986: Pharmacologic approaches to psychogenic polydipsia case reports

Badimon J.J.; Padro T.; Badimon L.; Bruseghini L.; Villaverde C.A., 1981: Pharmacologic aspects of thienylic acid

Fan D.; Morgan L.R.; Schneider C.; Blank H.; Roy S.; Wang Y.F.; Fan S., 1985: Pharmacologic assessment of regimen chemosensitivity in the soft agar assay effect of oxygen on human tumors

Rodina L.G.; Galushkina L.R., 1987: Pharmacologic assessment of tinctura valerianae neurotropic activity during central nervous system ischemia in frogs

Schaad U.B.; Mccracken G.H.Jr, 1981: Pharmacologic basis for anti microbial therapy of neo natal meningitis

Saegusa K.; Furukawa Y.; Ogiwara Y.; Takeda M.; Chiba S., 1987: Pharmacologic basis of responses to midazolam in the isolated cross perfused canine right atrium

Boerth, R. C.; Ryan, M. J.; Brody, M. J., 1970: Pharmacologic blockade of reflex vaso dilatation effects on postulated neuro humoral mechanisms

Ortez, R. A., 1977: Pharmacologic blockade of the effect of histamine on lung cyclic amp levels in normal and pertussis vaccinated mice

Schneiderman, B.; Isaacson, R. L., 1976: Pharmacologic changes in performance of normal and brain damaged rats

Seidel C.L.; Allen J.C., 1979: Pharmacologic characteristics and acto myosin content of aorta from neo natal rats

Rozhkova E.K.; Malyutina T.A.; Shishov B.A., 1980: Pharmacologic characteristics of cholino reception in somatic muscles of the nematode ascaris suum

Stahl S.M.; Yesavage J.A.; Berger P.A., 1982: Pharmacologic characteristics of meige dystonia differentiation from tardive dys kinesia

Buck S.H.; Helke C.J.; Burcher E.; Shults C.W.; O'donohue T.L., 1986: Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system

James M.K.; Cubeddu L.X., 1987: Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum

Boisse N.R.; Periana R.M.; Guarino J.J.; Kruger H.S.; Samoriski G.M., 1986: Pharmacologic characterization of acute chloridiazepoxide dependence in the rat

Behar J.; Biancani P., 1987: Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of oddi

Mais D.E.; Saussy D.L.Jr; Chaikhouni A.; Kochel P.J.; Knapp D.R.; Hamanaka N.; Halushka P.V., 1985: Pharmacologic characterization of human and canine thromboxane a 2 prostaglandin h 2 receptors in platelets and blood vessels evidence for different receptors

Krell R.D., 1979: Pharmacologic characterization of isolated rhesus monkey macaca mulatta bronchial smooth muscle

Fudala P.J.; Teoh K.W.; Iwamoto E.T., 1985: Pharmacologic characterization of nicotine induced conditioned place preference

Lieberman J.; Pollack S.; Lesser M.; Kane J., 1988: Pharmacologic characterization of tardive dyskinesia

Martinez Soler R.; Mas R.; Garateix A.; Menendez R., 1983: Pharmacologic characterization of the acetylcholine receptors in neurons of the central nervous system of zachrysia guanensis

Chakrin, L. W.; Krell, R. D., 1978: Pharmacologic characterization of the anti allergic activity of skf 78729 a

Dimartino M.J.; Griswold D.E.; Berkowtiz B.A.; Poste G.; Hanna N., 1987: Pharmacologic characterization of the antiinflammatory properties of a new dual inhibitor of lipoxygenase and cyclooxygenase

Friedman, W. F.; Hirschklau, M. J.; Printz, M. P.; Pitlick, P. T.; Kirkpatrick, S. E., 1976: Pharmacologic closure of patent ductus arteriosus in the premature infant

Schwartz R.H.; Rodriquez W.J.; Grundfast K.M., 1981: Pharmacologic compliance with antibiotic therapy for acute otitis media influence on subsequent middle ear effusion

Pasquel H., 1979: Pharmacologic considerations in determining efficacy of once daily sotalol administration to hypertensive patients

Topchii I.I., 1986: Pharmacologic control of microcirculatory disorders and hemosorption in chronic ischemic heart disease patients

Mueller K.; Nyhan W.L., 1982: Pharmacologic control of pemoline induced self injurious behavior in rats

Pierpaoli, W.; Maestroni, G. J. M., 1978: Pharmacologic control of the hormonally modulated immune response part 3 prolongation of allogeneic skin graft rejection and prevention of runt disease by a combination of drugs acting on neuro endocrine functions

Feld G.K.; Venkatesh N.; Singh B.N., 1986: Pharmacologic conversion and suppression of experimental canine atrial flutter differing effects of d sotalol quinidine and lidocaine and significance of changes in refractoriness and conduction

Benoit P.W.; Yagiela J.A.; Fort N.F., 1980: Pharmacologic correlation between local anesthetic induced myo toxicity and disturbances of intra cellular calcium distribution

Demicheli R.; Bonciarelli G.; Jirillo A.; Foroni R.; Petrosino L.; Targa L.; Garusi G., 1985: Pharmacologic data and technical feasibility of intraperitoneal doxorubicin administration

Green T.P.; Rybak L.P.; Mirkin B.L.; Juhn S.K.; Morizono T., 1981: Pharmacologic determinants of oto toxicity of furosemide in the chinchilla

Ruffolo R.R.Jr; Sulpizio A.C.; Nichols A.J.; Demarinis R.M.; Hieble J.P., 1987: Pharmacologic differentiation between prejunctional and postjunctional alpha 2 adrenoceptors by skf 104078

Mhatre, R. M.; Green, D.; Panasci, L. C.; Fox, P.; Woolley, P. V.; Schein, P. S., 1978: Pharmacologic disposition of chlorozotocin in mice

Kelley, J. M.; Adamson, R. H.; Cooney, D. A.; Jayaram, H. N.; Anandaraj, S., 1977: Pharmacologic disposition of dl alanosine in mice rats dogs and monkeys

Cysyk, R. L.; Adamson, R. H., 1976: Pharmacologic disposition of inosine di aldehyde nsc 118994 in mice rats dogs an monkeys

Polinsky R.J.; Kopin I.J.; Ebert M.H.; Weise V., 1981: Pharmacologic distinction of different orthostatic hypotension syndromes

Martinez Soler R.; Mas R.; Menendez R.; Garateix A., 1983: Pharmacologic distinctions in the acetylcholine and l glutamate receptors of an identical cell

Woodcock T.E.; Murkin J.M.; Farrar J.K.; Tweed W.A.; Guiraudon G.M.; Mckenzie F.N., 1987: Pharmacologic eeg suppression during cardiopulmonary bypass cerebral hemodynamic and metabolic effects of thiopental or isoflurane during hypothermia and normothermia

Aguwa C.N., 1986: Pharmacologic effect of an aqueous extract of rhigiocarya racemifera

Rene E.; Danzinger R.G.; Hofmann A.F.; Nakagaki M., 1982: Pharmacologic effect of somatostatin on bile formation in the dog enhanced ductular re absorption as the major mechanism of anti choleresis

Lemberger, L.; Rowe, H.; Carmichael, R.; Oldham, S.; Horng, J. S.; Bymaster, F. P.; Wong, D. T., 1978: Pharmacologic effects in man of a specific serotonin re uptake inhibitor

Luther R.R.; Ringham G.L.; Steinberg F.J.; Patterson K.J.; Jordan D.C.; Rollins D.E.; Tolman K.G., 1987: Pharmacologic effects of a 49816 a new high ceiling diuretic

Winsor D.W.; Winsor T.; Krohn B.G.; Bernett J.R., 1982: Pharmacologic effects of a nitrate coronary vaso dilator on cardiac perfusion and function measured semi quantitatively

Khan M.M.; Sansoni P.; Engleman E.G.; Melmon K.L., 1985: Pharmacologic effects of autacoids on subsets of t cells regulation of expression function of histamine h 2 receptors by a subset of suppressor cells

Kharchenko E.P.; Bagrov A.Ya; Sokolova T.V., 1987: Pharmacologic effects of exogenous histones on muscles

Maselli, R.; Casal, G. L.; Ellis, E. F., 1970: Pharmacologic effects of intra venously administered aminophylline in asthmatic children

Chrousos G.P.; Brown T.; Bercu B.B., 1982: Pharmacologic effects of melatonin on hypothalamic adeno hypophyseal function in the nonhuman primate

Kakemi M.; Sasaki H.; Saeki K.; Endoh M.; Katayama K.; Koizumi T., 1983: Pharmacologic effects of metformin in relation to its disposition in alloxan diabetic rats

Freeman, A. I.; Al-Bussam, N.; O'malley, J. A.; Stutzman, L.; Bjornsson, S.; Carter, W. A., 1977: Pharmacologic effects of poly inosinic acid poly cytidylic acid in man

Cremaschi G.A.; Sterin Borda L.; Genaro A.M.; Borda E.S.; Braun M., 1984: Pharmacologic effects on mouse isolated atria of immunoglobulins directed against class i histocompatibility antigens

Kim M.K.; Chan C C.; Nussenblatt R.B.; Palestine A.G., 1987: Pharmacologic effects on the expression of class ii histocompatibility antigen in experimental endotoxin induced uveitis

Hartman D.F.; Goode R.L., 1987: Pharmacologic enhancement of composite graft survival

Larson S.M.; Rasey J.S.; Grunbaum Z.; Allen D.R., 1979: Pharmacologic enhancement of gallium 67 tumor to blood ratios for emt 6 sarcoma balb c mice

Bhattacharyya B.; Sokoll M.D.; Cannon J.G.; Long J.P., 1987: Pharmacologic evaluation and structure activity relationships of a series of hemicholinium 3 hc 3 analogs

Shook J.E.; Pelton J.T.; Wire W.S.; Hirning L.D.; Hruby V.J.; Burks T.F., 1987: Pharmacologic evaluation of a cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro

Hudgins, P. M.; Stubbins, J. F., 1969: Pharmacologic evaluation of a new series of cholinergic antagonists containing an agonist moiety di methylaminoethyl benzilate ethiodide lachesine acetyl choline carbachol histamine phenylephrine autonomic rat rabbit

Hastings, S. G.; Smith, R. D.; Corey, R. M.; Essenburg, A. D.; Pettway, C. E.; Tessman, D. K., 1977: Pharmacologic evaluation of ci 775 racemic 1 2 3 4 di methoxyphenylethylamino 3 3 methylphenoxy 2 propanol hydro chloride a cardio selective beta adrenergic antagonist

Batenhorst, R. L.; Batenhorst, A. S.; Graves, D. A.; Foster, T. S.; Kung, M.; Gural, R. P.; Amkraut, H. J., 1986: Pharmacologic evaluation of loratadine sch 29851 chlorpheniramine and placebo

Mccracken, G. H-Jr ; Ginsburg, C. M.; Clahsen, J. C.; Thomas, M. L., 1978: Pharmacologic evaluation of orally administered antibiotics in infants and children effect of feeding on bio availability

Wong, S.; Gardocki, J. F.; Pruss, T. P., 1973: Pharmacologic evaluation of tolectin tolmetin mcn 2559 and mcn 2891 5 p chlorobenzoyl 1 4 alpha trimethyl pyrrole 2 acetic acid 2 anti inflammatory agents

Nau H.; Loescher W., 1986: Pharmacologic evaluation of various metabolites and analogs of valproic acid teratogenic potencies in mice

Fuller, R. W.; Snoddy, H. D.; Molloy, B. B., 1976: Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus pituitary adrenal function in rats

Sharpe L.G.; Pickworth W.B., 1981: Pharmacologic evidence for a tonic muscarinic inhibitory input to the edinger westphal nucleus in the dog

Gorell J.M.; Czarnecki B., 1986: Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release

Levy D.; Dorus E.; Shaughnessy R.; Yasillo N.J.; Pandey G.N.; Janicak P.G.; Gibbons R.D.; Gaviria M.; Davis J.M., 1985: Pharmacologic evidence for specificity of pursuit dysfunction to schizophrenia lithium carbonate associated with abnormal pursuit

Simon P.; Chermat R.; Puech A.J., 1983: Pharmacologic evidence of the stimulation of central alpha adrenergic receptors

Selden E.M.; Convery M.E.; Stites M.M.; Domino E.F., 1986: Pharmacologic evidence that high dose chronic amitriptyline and desipramine down regulate alpha 2 receptor mediated hypothermia in the rat

Sprouse J.S.; Baker T.; Riker W.F.Jr, 1985: Pharmacologic excitability of rat motor nerve endings the effect of adrenalectomy on neostigmine induced fasciculations

Frame, P. T.; Phair, J. P.; Watanakunakorn, C.; Bannister, T. W. P., 1977: Pharmacologic factors associated with gentamicin nephro toxicity in rabbits

Gilbert R.; Rattan S.; Goyal R.K., 1984: Pharmacologic identification activation and antagonism of 2 muscarine receptor subtypes in the lower esophageal sphincter

Gaginella, T. S.; Rimele, T. J.; O'dorisio, T. M.; Dorff, R. J., 1980: Pharmacologic identification of muscarinic receptors in the pylorus of the cat by binding of tritium labeled quinuclidinyl benzilate

Christensen, J., 1970: Pharmacologic identification of the lower esoohageal sphincter

Delafuente J.C.; Panush R.S., 1988: Pharmacologic immunoenhancement in the elderly in vitro effects of isoprinosine

Myslobodsky, M.; Weiner, M., 1976: Pharmacologic implications of hemispheric asymmetry

Mangiapane M.L.; Simpson J.B., 1979: Pharmacologic independence of subfornical organ receptors mediating drinking

Warltier, D. C.; Gross, G. J.; Brooks, H. L., 1981: Pharmacologic induced vs. ischemia induced coronary artery vaso dilation

Shaikh A.A.; Shaikh S.A.; Castracane V.D., 1980: Pharmacologic induction of luteolysis in cynomolgus monkeys macaca fascicularis

Melis, G. B.; Paoletti, A. M.; Strigini, F.; Fabris, F. M.; Canale, D.; Fioretti, P., 1987: Pharmacologic induction of multiple follicular development improves the success rate of artificial insemination with husband's semen in couples with male related or unexplained infertility

Sobotka, P.; Chaloupka, Z.; Rokyta, R., 1978: Pharmacologic influence of cortical evoked potentials in rats during barbiturate sleep

Krieglsteiner, P.; Lohninger, A.; Fischbach, F.; Riedl, W.; Szudrowicz, D.; Erhardt, W.; Bluemel, G., 1980: Pharmacologic influencing of fetal phospho lipid synthesis 4. influencing the di palmitoyl lecithin content of fetal lung by betamethasone

Mottolese M.; Nicotra M.R.; Natali P.G., 1983: Pharmacologic inhibition of experimentally induced systemic lupus erythematosus like deposition of immuno globulins in skin nuclei

Caritis S.N.; Edelstone D.I.; Mueller Heubach E., 1979: Pharmacologic inhibition of preterm labor

Bertele V.; Falanga A.; Tomasiak M.; Chiabrando C.; Cerletti C.; De Gaetano G., 1984: Pharmacologic inhibition of thromboxane synthetase and platelet aggregation modulatory role of cyclooxygenase products

Moriconi S.; Bonini S., 1988: Pharmacologic inhibition piroxicam of the cytologic conjunctival reactivity in patients with allergic conjunctivitis

Wallin, R. F.; Blackburn, W. H.; Napoli, M. D., 1970: Pharmacologic interactions of albutoin with other anti convulsant drugs

Davis W.M.; Borne R.F., 1984: Pharmacologic investigation of compounds related to 3 4 methylene di oxy amphetamine

Dodds W.J.; Christensen J.; Dent J.; Arndorfer R.C.; Wood J.D., 1979: Pharmacologic investigation of primary peristalsis in smooth muscle portion of opossum esophagus

Hashimoto, K.; Chiba, S., 1969: Pharmacologic isolation of sino atrial activity from effects of neural excitation by use of tetrodo toxin

Sakamoto H.; Huszar G., 1986: Pharmacologic levels of nitrendipine do not affect actin myosin interaction in the human uterus and placenta

Heinonen P.K.; Pihkala H., 1985: Pharmacologic management and controlled cord traction in the third stage of labor

Leventhal, A.; Pfau, A., 1978: Pharmacologic management of post operative over distension of the bladder

Campos F.; Arruda F., 1981: Pharmacologic manipulations of brain catecholamines and the behavior of callithrix jacchus marmoset

Copelan E.A.; Johnson S.C.; Grever M.R.; Sheridan J.F.; Tutschka P.J., 1988: Pharmacologic marrow purging in murine t cell leukemia

Merino V.L.; Matoses S.L.; Campos V.C.; Matoses M.L.; Requena J.E., 1980: Pharmacologic model of experimental asthma in the dog by neostigmine

Hanson S.R.; Reidy M.A.; Hattori A.; Harker L.A., 1982: Pharmacologic modification of acute vascular graft thrombosis

Wetstein L.; Simson M.B.; Feldman P.D.; Harken A.H., 1982: Pharmacologic modification of myo cardial ischemia

Marmor M.F.; Negi A., 1986: Pharmacologic modification of subretinal fluid absorption in the rabbit eye

Maia, H. Jr ; Salinas, L. A.; Fernandez, E. O.; Pauerstein, C. J., 1977: Pharmacologic modification of the time course of ovum transport in guinea pigs

Rocklin R.E.; Habarek Davidson A., 1984: Pharmacologic modulation in vitro of human histamine induced suppressor cell activity

Marak, G. E. Jr ; De-Kozak, Y.; Faure, J. P.; Rao, N. A.; Romero, J. L.; Ward, P. A.; Till, G. O., 1988: Pharmacologic modulation of acute ocular inflammation i. adenosine

Darius H.; Stahl G.L.; Lefer A.M., 1987: Pharmacologic modulation of atp release from isolated rat hearts in response to vasoconstrictor stimuli using a continuous flow technique

Parker C.W., 1982: Pharmacologic modulation of release of arachidonic acid from human mononuclear cells and lymphocytes by mitogenic lectins

Urata C.; Siraganian R.P., 1985: Pharmacologic modulation of the immunoglobulin e or calcium ionophore a 23187 mediated calcium influx phospholipase activation and histamine release in rat basophilic leukemia cells

Sullivan T.J., 1982: Pharmacologic modulation of the whealing response to histamine in human skin identification of doxepin as a potent in vivo inhibitor

Rosen, T. S.; Pippenger, C. E., 1976: Pharmacologic observations on the neo natal withdrawal syndrome

Sewell R.B.; Grinpukel S.A.; Zinsmeister A.R.; Larusso N.F., 1988: Pharmacologic perturbation of rat liver lysosomes effects on release of lysosomal enzymes and of lipids into bile

Shiraki Y.; Sakai K., 1983: Pharmacologic potency and selectivity of a new broncho dilator agent 2 3 di hydro 7 methyl 9 phenyl 1h pyrazolo 1 2 a indazolium bromide on canine tracheal preparations in vivo and in vitro

Dungan, K. W.; Cho, Y. W.; Gomoll, A. W.; Aviado, D. M.; Lish, P. M., 1968: Pharmacologic potency and selectivity of a new broncho dilator agent soterenol autonomic mj 1992 autonomic isoproterenol autonomic cat dog guinea pig

Mcdougal W.S., 1982: Pharmacologic preservation of renal mass and function in obstructive uropathy

Koller W.C.; Rubino F.; Gupta S., 1987: Pharmacologic probe with progabide of gaba mechanisms in essential tremor

Nasrallah H.A.; Dunner F.J.; Mccalley Whitters M.; Smith R.E., 1986: Pharmacologic probes of neurotransmitter systems in tardive dyskinesia implications for clinical management

Gray J.A.; Kavlock R.J., 1988: Pharmacologic probing of amphotericin b induced renal dysfunction in the neonatal rat

Gray J.A.; Kavlock R.J., 1987: Pharmacologic probing of mercuric chloride induced renal dysfunction in the neonatal rat

Gray J.A.; Kavlock R.J., 1986: Pharmacologic probing of renal development in the neonatal rat

James, T. N.; Bear, E. S.; Frink, R. J.; Urthaler, F., 1971: Pharmacologic production of atrio ventricular block with and without initial bundle branch block

Killick S.; Elstein M., 1987: Pharmacologic production of luteinized unruptured follicles by prostaglandin synthetase inhibitors

Tutwiler G.F.; Tuman R.W.; Joseph J.M.; Mihan B.B.; Fawthrop H.; Brentzel H.J., 1986: Pharmacologic profile and insulin secretagogue effect of linogliride mcn 3935 a new orally effective hypoglycemic agent

El-Azab, J.; Stewart, P. B., 1977: Pharmacologic profile of a new anti allergic compound prd 92 ea

Martin G.E.; Williams M.; Pettibone D.J.; Yarbrough G.G.; Clineschmidt B.V.; Jones J.H., 1984: Pharmacologic profile of a novel potent direct acting dopamine agonist dextro 4 propyl 9 hydroxynaphthoxazine

Snyder D.W.; Bernstein P.R., 1987: Pharmacologic profile of chemically stable analogs of peptide leukotrienes

Baizman E.R.; Ezrin A.M.; Ferrari R.A.; Luttinger D., 1987: Pharmacologic profile of fezolamine fumarate a nontricyclic antidepressant in animal models

Battaglia G.; Brooks B.P.; Kulsakdinun C.; De Souza E.B., 1988: Pharmacologic profile of mdma 3 4 methylenedioxymethamphetamine at various brain recognition sites

Tutwiler, G. F.; Kirsch, T.; Mohrbacher, R. J.; Ho, W., 1978: Pharmacologic profile of methyl 2 tetradecyl glycidate mcn 3716 an orally effective hypo glycemic agent

Hay D.W.P.; Muccitelli R.M.; Tucker S.S.; Vickery Clark L.M.; Wilson K.A.; Gleason J.G.; Hall R.F.; Wasserman M.A.; Torphy T.J., 1987: Pharmacologic profile of skf 104353 a novel potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways

Byington K.H., 1987: Pharmacologic properties of a phosphate ester of dopamine

O'donnell M.; Welton A.F., 1984: Pharmacologic properties of fpl 55712 sodium 7 3 4 acetyl 3 hydroxy 2 propylphenoxyl 2 hydroxypropoxy 4 oxo 8 propyl 4h 1 benzopyran 2 carboxylate administered by aerosol

Chojnacka-Wojcik, E.; Hano, J.; Sieroslawska, J.; Sypniewska, M., 1975: Pharmacologic properties of gamma amino butyric acid and its derivatives part 5 anti convulsant action of alpha beta and gamma phenyl derivatives of gamma amino butyric acid and their lactams

Du-Charme, D. W.; Freyburger, W. A.; Graham, B. E.; Carlson, R. G., 1973: Pharmacologic properties of minoxidil a new hypotensive agent

Cebo B.; Krupinska J.; Mazur J., 1979: Pharmacologic properties of some derivatives of n 22 carboxyphenyl 4 phenoxy acetamide

Catterall W.A., 1980: Pharmacologic properties of voltage sensitive sodium channels in chick muscle fibers developing in vitro

Wong L.; Hendeles L.; Weinberger M., 1981: Pharmacologic prophylaxis of allergic rhinitis relative efficacy of hydroxyzine and chlorpheniramine

Allegra L.; Bianco S.; Cogo A.; Longo P., 1983: Pharmacologic protection from induced bronchoconstriction in 2 non native asthmatics while mountaineering

Kirpatovskii V.I.; Onishchenko N.A.; Kozyreva G.A.; Blyumkin V.N., 1981: Pharmacologic protection of kidneys from ischemic damage comparative evaluation of the efficacy of agents from various pharmacologic groups

Kirpatovskii V.I.; Onishchenko N.A.; Petrosova V.N.; Kozyreva T.A., 1982: Pharmacologic protection of the kidneys from ischemic damage the mechanism by which donor kidneys are protected against ischemia by drugs from various pharmacologic groups

Egan B.; Neubig R.; Julius S., 1985: Pharmacologic reduction of sympathetic drive increases platelet alpha 2 receptor number

Gipson S.L.; Stovall T.G.; Elkins T.E.; Crumrine R.S., 1986: Pharmacologic reduction of the risk of aspiration

Krell, R. D.; Chakrin, L. W., 1978: Pharmacologic regulation of antigen induced mediator release from canine lung

Gabrielyan E.S.; Akopov S.E., 1982: Pharmacologic regulation of the functional state of thrombocytes and erythrocytes

Wibo M.; Deroth L.; Godfraind T., 1988: Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta kinetic and equilibrium studies

Byfield J.E.; Calabro Jones P.; Klisak I.; Kulhanian F., 1982: Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5 fluoro uracil or ftorafur and x rays

Flynn, E. J.; Cerreta, K. V.; Spector, S., 1977: Pharmacologic response to pento barbital in actively immunized mice

Cerreta K.V.; Flynn E.J.; Spector S., 1979: Pharmacologic response to pento barbital in passively immunized mice

Christian, C. N.; Nelson, P. G.; Bullock, P.; Mullinax, D.; Nirenberg, M., 1978: Pharmacologic responses of cells of a neuro blastoma x glioma hybrid clone and modulation of synapses between hybrid cells and mouse myo tubes

Sato K.; Sato F., 1981: Pharmacologic responsiveness of isolated single eccrine sweat glands

Szarek J.L.; Evans J.N., 1988: Pharmacologic responsiveness of rat parenchymal strips bronchi and bronchioles

Novaes A.P.D.; Bugner M., 1986: Pharmacologic restraint of bovines with gallamine triethiodide

Woosley R.L.; Reele S.B.; Roden D.M.; Nies A.S.; Oates J.A., 1982: Pharmacologic reversal of hypotensive effect complicating anti arrhythmic therapy with bretylium

Hori N.; Auker C.R.; Braitman D.J.; Carpenter D.O., 1982: Pharmacologic sensitivity of amino acid responses and synaptic activation of in vitro prepyriform neurons

Finn I.B.; Holtzman S.G., 1987: Pharmacologic specificity of tolerance to caffeine induced stimulation of locomotor activity

Moore, L. G.; Brewer, G. J.; Oelshlegel, F. J-Jr ; Brewer, L. F.; Schoomaker, E. B., 1977: Pharmacologic stimulation of erythrocyte 2 3 di phospho glycerate production in vivo

Rado, J. P.; Simatupang, T.; Boer, P.; Dorhout-Mees, E. J., 1978: Pharmacologic studies in bartters syndrome effect of 1 deamino 8 d arginine vasopressin and indomethacin on renal concentrating operation

Simatupang, T. A.; Rado, J. P.; Boer, P.; Geyskes, G. G.; Vos, J.; Dorhout-Mees, E. J., 1978: Pharmacologic studies in bartters syndrome opposite effects of treatment with anti kaliuretic and anti prostaglandin drugs part 1

Shu H.; Chu Y.; Lin J.; Zhao Z., 1980: Pharmacologic studies of 15 methyl prostaglandin f 2 alpha

Liu H J.; Sato K.; Shih H C.; Shibuya T., 1985: Pharmacologic studies of central action of zopiclone effects on locomotor activity and brain monoamines in rats

Sato K.; Hong Y L.; Yang M S.; Shibuya T.; Kawamoto H.; Kitagawa H., 1985: Pharmacologic studies of central actions of zopiclone influence on brain monoamines in rats under stressful condition

Sato K.; Hong Y L.; Yang M S.; Shibuya T., 1985: Pharmacologic studies of central actions of zopiclone influence on brain monoamines in rats under stressful conditions

Ho, D. H. W.; Brown, N. S.; Benvenuto, J.; Mccredie, K. B.; Buckels, D.; Freireich, E. J., 1977: Pharmacologic studies of continuous infusion of arabinosyl cytosine by liquid infusion system

Huang K.; Et Al, 1983: Pharmacologic studies of radix paeoniae rubia in experimental tumors with special reference to growth and metastases

Liu H J.; Sato K.; Shih H C.; Shibuya T.; Kawamoto H.; Kitagawa H., 1985: Pharmacologic studies of the central action of zopiclone effects on locomotor activity and brain monoamines in rats

Blaszczyk, B.; Gieldanowski, J., 1976: Pharmacologic studies on anti inflammatory activity of di keto piperidine and tri keto piperidine derivatives

Manolov P.; Pavlova N.; Kr"steva S., 1985: Pharmacologic studies on antiulcerogenic antiulcerin a preparation

Fan L L.; O'keefe D.D.; Powell W.W.J.Jr, 1985: Pharmacologic studies on radix puerariae effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia

Fan L L.; Zeng G Y.; Zhou Y P.; Zhang L Y.; Cheng Y S., 1982: Pharmacologic studies on radix puerariae effects of puerariae flavones on coronary circulation cardiac hemodynamics and myo cardial metabolism in dogs

Tseng, K. Y.; Chou, Y. P.; Chang, L. Y.; Fan, L. L., 1975: Pharmacologic studies on radix puerariae part 1 effects of puerariae on blood pressure vascular reactivity cerebral and peripheral circulation in dogs

Aguwa C.N.; Lawal A.M., 1988: Pharmacologic studies on the active principles of calliandra portoricensis leaf extracts

Giles, R. E.; Williams, J. C.; Finkel, M. P., 1977: Pharmacologic studies on w 10294a 1 2 3 4 tetra hydro 8 9 di methoxy 3 2 piperidinoethyl 5h 1 benzopyrano 3 4 c pyridin 5 one di hydro chloride a new broncho dilator

Meyers, B. R.; Hirschman, S. Z.; Wormser, G.; Gartenberg, G.; Srulevitch, E., 1978: Pharmacologic studies with cefaclor a new oral cephalosporin

Chin-Peoples-Liberation-Army-88th-Hosp ; Shanghai-Res-Inst-Pharm-Ind ; Shanghai-First-Tradit-Chin-Med-Fact ; Shanghai-Med-Mater-Co ; Tradit-Chin-Med-Res-Lab, 1976: Pharmacologic study and clinical observations on muscle relaxant han chi sung

Manolov P.; Lambev I.; Simeonova K.; Klouchek E.; Pavlova N.; Krushkov I.; Kr"steva S., 1985: Pharmacologic study of algolin phytopreparation

Li D.; Zhang S.; Hao X.; Ma K.; Tan X.; Wang Z.; Li N., 1980: Pharmacologic study of colchicinamide

Millhorn D.E.; Eldridge F.L.; Waldrop T.G., 1981: Pharmacologic study of respiratory afterdischarge

Boyadzhieva N.; Visheva N.; Milanov S.; Ovcharov R., 1986: Pharmacologic study of the influence of dopaminergic agents upon prolactin secretion

Kubo, M.; Matsuda, H.; Arichi, S., 1984: Pharmacologic study on animal crude drugs 1. bufonis venenun bezoar bovis and moschus 1. effects on ischemic heart disease induced by the experimental disseminated intra vascular coagulation

Balderman S.C.; Aldridge J., 1986: Pharmacologic support of the myocardium following aortocoronary bypass surgery a comparative study

O'donnell K.; Keogh B.; Cantin A.; Crystal R.G., 1987: Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis

Ciprandi G.; Scordamaglia A.; Bagnasco M.; Canonica G.W., 1987: Pharmacologic treatment of adverse reactions to foods comparison of different protocols

Bianco C.; Cosmi F.; Ricca M., 1986: Pharmacologic treatment of arterial hypertension and bronchial hyperreactivity

De Bernardi M.; Santucci V.; Colombo L., 1988: Pharmacologic treatment of benign prostatic hyperplasia a multicenter clinical study with mepartricin

Prien, R. F.; Caffey, E. M-Jr, 1977: Pharmacologic treatment of elderly patients with organic brain syndrome a survey of 12 veterans administration hospitals

Kasiske B.L.; O'donnell M.P.; Garvis W.J.; Keane W.F., 1988: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5 6 nephrectomy model of chronic renal failure

Porter J.M.; Baur G.M., 1982: Pharmacologic treatment of intermittent claudication

Koller W.C., 1986: Pharmacologic treatment of parkinsonian tremor

Koller W.C., 1984: Pharmacologic trials in the treatment of cerebellar tremor

Spacil J.; Linhart J., 1980: Pharmacologic vaso dilation

Nishida, Y.; Suzuki, S.; Miyamoto, T., 1985: Pharmacological action of 5' methylthioadenosine on isolated rabbit aorta strips

Kasama T.; Fujii Y.; Aida Y.; Mayuzumi K.; Mayuzumi Y.; Goto M.; Gomita Y.; Moriyama M.; Ichimaru Y., 1983: Pharmacological action of a bromazepam suppository

Pan S Y.; Et Al, 1986: Pharmacological action of astragalus membranaceus on the central nervous system in mice

Kameyama, T.; Nabeshima, T.; Yamaguchi, K.; Kamata, K.; Okuyama, S.; Tsuji, H.; Sakakibara, S., 1981: Pharmacological action of eptazocine levo 1 4 di methyl 10 hydro 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonine 3. central action of eptazocine

Kameyama, T.; Nabeshima, T.; Yamaguchim, K.; Ukai, M.; Okuyama, S.; Sakakibara, S., 1981: Pharmacological action of eptazocine levo 1 4 di methyl 10 hydroxy 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonine 1. relationship between the analgesic action of eptazocine and brain catecholamine

Kameyama, T.; Nabeshima, T.; Yamaguchi, K.; Kamata, K.; Ukai, M.; Okuyama, S.; Sakakibara, S., 1981: Pharmacological action of eptazocine levo 1 4 di methyl 10 hydroxy 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonine 2. relationship between the analgesic action of eptazocine and brain 5 hydroxy tryptamine

Nabeshima, T.; Yamada, S.; Yamaguchi, K.; Matsuno, K.; Kameyama, T.; Sakakibara, S.; Matsumoto, S., 1983: Pharmacological action of eptazocine levo 1 4 di methyl 10 hydroxy 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonine 4. narcotic agonist and antagonist actions of eptazocine

Sakakibara S., 1983: Pharmacological action of eptazocine levo 1 4 di methyl 10 hydroxy 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonine effects of eptazocine on spontaneous movements in mice

Nabeshima, T.; Yamada, S.; Kameyama, T., 1986: Pharmacological action of eptazocine levo 1 4 dimethyl 10 hydroxy 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonine v. a comparison of eptazocine pentazocine and morphine with regard to the ability of tolerance development after successive administration

Sasaki T.; Kassell N.F.; Turner D.M.; Comair Y.G.; Yamashita M.; Fujiwara S., 1985: Pharmacological action of fpl 55712 7 3 4 acetyl 3 hydroxy 2 propylphenoxy 2 hydroxypropoxy 4 oxo 8 propyl 4h 1 benzopyran 2 carboxylic acid monosodium salt on canine cerebral arterial segments

Haranaka R.; Okada N.; Kosoto H.; Ohwada S.; Kobayashi M.; Yoshida H., 1986: Pharmacological action of hachimijiogan ba wei wan on the metabolism of aged subjects

Muir C.K.; Hoe K.F., 1982: Pharmacological action of leaves of plumeria acuminata

Nagai K.; Mori T.; Ookura M.; Tsujimoto H.; Nakagawa H., 1984: Pharmacological action of mazindol on behaviors and metabolism

Taddei I.; Taddei E.; Giachetti D., 1986: Pharmacological action of morphine in the chronically treated rat with clomipramine

Kizawa Y.; Takayanagi I.; Shinkai M.; Ohno Y., 1988: Pharmacological action of nicotine in the isolated urinary bladder from rabbit special reference to the chronic nicotine treatment

Danneberg P.; Boeke Kuhn K.; Bechtel W.D.; Lehr E., 1986: Pharmacological action of some known and possible metabolites of brotizolam

Singh G.B.; Leach G.D.H.; Atal C.K., 1987: Pharmacological actions and acute toxicity of methyl and phenyl 3 methoxy 4 hydroxy styryl ketones

Mackintosh D.; Mason R.M., 1988: Pharmacological actions of 17 beta estradiol on articular cartilage chondrocytes and chondrosarcoma chondrocytes in the absence of estrogen receptors

Hikino H.; Sato H.; Yamada C.; Konno C.; Ohizumi Y.; Endo K., 1979: Pharmacological actions of aconitum roots

Lee J.H.; Lee S.B.; Cho B.H.; Cho K.C., 1979: Pharmacological actions of alpha tri thio acetaldehyde

Hikino H.; Kiso Y.; Ogata M.; Konno C.; Aisaka K.; Kubota H.; Hirose N.; Ishihara T., 1984: Pharmacological actions of analogs of feruloylhistamine an imidazole alkaloid of ephedra roots

Salzmann R.; Bormann G.; Herzig J.W.; Markstein R.; Scholtysik G., 1985: Pharmacological actions of app 201 533 3 amino 6 methyl 5 phenyl 2 1h pyridinone a novel cardiotonic agent

Hachisu M.; Koeda T., 1980: Pharmacological actions of beta adrenoceptor blockers with reference to their physicochemical properties

Thompson, E. B.; Klotz, I. M., 1982: Pharmacological actions of di aspirins potential anti sickling agents 1. a preliminary study

Thompson E.B.; Klotz I.M., 1985: Pharmacological actions of diaspirins potential antisickling agents analgesic and anti inflammatory effects

Garcia M., 1984: Pharmacological actions of diethylcarbamazine citrate on the isolated rabbit tracheal chain and atria

Takeo S.; Tanonaka K.; Anan M.; Hiraga S., 1987: Pharmacological actions of dopamine sulfoconjugate on cardiovascular system

Salzmann R.; Scholtysik G.; Markstein R.; Bormann G., 1988: Pharmacological actions of dpn 205 734 a novel cardiotonic agent

Kasahara Y.; Hikino H., 1984: Pharmacological actions of ephedra internodes and nodes

Kumar A.; Pandey V.B.; Seth K.K.; Dasgupta B.; Bhattacharya S.K., 1986: Pharmacological actions of fumariline isolated from fumaria indica seeds

Saad, S. F., 1978: Pharmacological actions of gamma amino butyric acid a review article

Kita T.; Hata T.; Kawashima Y.; Kaku T.; Itoh E., 1981: Pharmacological actions of ginseng saponin in stressed mice

Clement J.G., 1979: Pharmacological actions of hs 6 an oxime on the neuro muscular junction

Jessup C.L.; Jessup R.; Wayne M., 1986: Pharmacological actions of ici 180080 a novel thromboxane receptor antagonist

Adeagbo A.S.O.; Magbagbeola A.O., 1985: Pharmacological actions of ifenprodil in the rat isolated anococcygeus muscle

Sakurada, T.; Kohno, H.; Tadano, T.; Kisara, K., 1977: Pharmacological actions of intra cerebrally administered poly amines in mice

Fukawa K.; Bando K.; Hatanaka Y.; Ohba S.; Honda H.; Saitoh K.; Nakazato K.; Irino O.; Nagawa Y.; Nagaoka A., 1985: Pharmacological actions of iprazochrome on the vascular system

Rao A.V.N.A.; Prabhakar M.C., 1987: Pharmacological actions of leprapinic acid a lichen metabolite

Takayanagi I.; Ohashi M.; Sato T., 1986: Pharmacological actions of leukotrienes c 4 d 4 and e 4 on guinea pig isolated tenia cecum as a preparation to study leukotrienes

Azuma, H.; Hironaka, Y.; Tamaoki, H.; Kubota, T., 1976: Pharmacological actions of olmidine a new anti hypertensive drug in the alimentary canal

Kasahara Y.; Saito E.; Hikino H., 1983: Pharmacological actions of pinellia ternata tubers and zingiber officinale rhizomes

Shibuya T.; Sato K.; Nakano M.; Liu H J.; Hara I., 1988: Pharmacological actions of s adenosyl l methionine sulfate tosylate fo 1561 first report effects on the central nervous system

Sato K.; Nakano M.; Hara I.; Aoki M.; Takagi K.; Shibuya T., 1988: Pharmacological actions of s adenosyl l methionine sulfate tosylate fo 1561 second report effects on the experimental cerebral ischemic animals

Abe, H.; Sakaguchi, M.; Yamada, M.; Arichi, S.; Odashima, S., 1980: Pharmacological actions of saiko saponins isolated from bupleurum falcatum 1. effects of saiko saponins on liver function

Ruedell E.; Bonte W.; Sprung R.; Kuessner H.; Sellin J H.; Frauenrath C., 1981: Pharmacological actions of small doses of higher aliphatic alcohols

Hemsworth B.A.; Shreeve S.M.; Veitch G.B.A., 1984: Pharmacological actions of some cyclic analogs of choline

Calixto, J. B.; Nicolau, M.; Rae, G. A., 1986: Pharmacological actions of tannic acid i. effects on isolated smooth and cardiac muscles and on blood pressure

Takahashi, R. N.; De-Lima, T. C. M.; Morato, G. S., 1986: Pharmacological actions of tannic acid ii. evaluation of central nervous system activity in animals

Barman T.K.; Chatterjee G.K.; Nag Chaudhuri A.K.; Pal S.P., 1980: Pharmacological actions of the extract of morus indica roots

El Tahir K.E.H.; Ageel A.M.; Mekkawi A.G.; Bashir A.K.; Mossa J.S.; Khaled S.A., 1987: Pharmacological actions of the leaves of solenostemma argel hayne spasmolytic and uterine relaxant activities

Mueller Schweinitzer E., 1984: Pharmacological actions of the main metabolites of dihydroergotamine

Ohizumi Y., 1987: Pharmacological actions of the marine toxins ciguatoxin and maitotoxin isolated from poisonous fish

Aceto M.D.; Harris L.S.; Woods J.H.; Katz J.L.; Smith C.B.; Medzihradsky F.; Jacobson A.E.; Shiotani S., 1985: Pharmacological actions of the racemic and the enantiomeric 1 4 dimethyl 10 hydroxy 2 3 4 5 6 7 hexahydro 1 6 methano 1h 4 benzazonines c homobenzomorphans

Tamaki, H.; Saito, K., 1978: Pharmacological actions of timepidium bromide on the motility of visceral smooth muscles and the secretion of digestive juice in experimental animals

Casals Stenzel J.; Muacevic G.; Weber K H., 1987: Pharmacological actions of web 2086 a new specific antagonist of platelet activating factor

Nataf, N.; Gourmel, B.; Rossignol, P., 1978: Pharmacological actions on hypoxic increase of rat brain cortex extracellular potassium ion

Mimura, T.; Terada, T.; Iwai, M.; Kohda, I.; Take, S.; Maeda, K.; Aonuma, S., 1983: Pharmacological activation of human serum immuno globulin g by chemical modification and active subfragments 1. induction of anti ulcerogenic activity by chemical cleavage of inter chain di sulfide bonds in human immuno globulin g and properties of active subfragments

Mimura, T.; Iwai, M.; Terada, T.; Kohda, I.; Tsujikawa, K.; Maeda, K.; Aonuma, S., 1983: Pharmacological activation of human serum immuno globulin g by chemical modification and active subfragments 2. inhibitory effects of carboxamide methylated l chain from human serum immuno globulin g on various ulcer models and its inhibition mechanism

Mcclellan A.D.; Farel P.B., 1985: Pharmacological activation of locomotor patterns in larval and adult frog spinal cords

Kobayashi M.; Ohata K., 1983: Pharmacological activities of a kinin released from rat plasma by catheptic enzyme in rat stomach

Gutierrez J.M.; Lomonte B.; Chaves F.; Moreno E.; Cerdas L., 1986: Pharmacological activities of a toxic phospholipase a isolated from the venom of the snake bothrops asper

Bove F.C.; Haarstad V.B., 1979: Pharmacological activities of acetal derivatives of hemicholinium 3

Caccia S.; Carli M.; Garattini S.; Poggesi E.; Rech R.; Samanin R., 1980: Pharmacological activities of clobazam and diazepam in the rat relation to drug brain levels

Inoue H.; Mori T.; Shibata S.; Saito H., 1987: Pharmacological activities of glycyrrhetinic acid derivatives analgesic and anti type iv allergic effects

Bianchini P.; Osima B.; Parma B.; Nader H.B.; Dietrich C.P., 1982: Pharmacological activities of heparins obtained from different tissues enrichment of heparin fractions with high lipo protein lipase anti hemolytic and anti coagulant activities by molecular sieving and anti thrombin iii affinity chromatography

Cazzulani P.; Pietra C.; Abbiati G.A.; Ceserani R.; Oliva D.; Civelli M.; Tajana A.; Nardi D., 1988: Pharmacological activities of the main metabolite of flavoxate 3 methylflavone 8 carboxylic acid

Mycroft F.J.; Bhargava H.N.; Wei E.T., 1987: Pharmacological activities of the mif 1 analogues pro leu gly tyr pro leu gly and pareptide

Zhdanov R.I.; Kadenatsi I.B.; Moshkovskii J.S.; Lavretskaya E.P.; Piruzyan L.A., 1979: Pharmacological activity and distribution in vivo of para magnetic models of some psychotropic compounds

Sauvaire D.; Michel A.; Serrano J.J.; Richard M., 1987: Pharmacological activity and toxicity of apyramide comparison with non steroidal anti inflammatory agents

Holsapple M.P.; Munson A.E.; Freeman A.S.; Martin B.R., 1982: Pharmacological activity and toxicity of phencyclidine and phenyl cyclo hexene a pyrolysis product

Kirichek L.T., 1979: Pharmacological activity and toxicity of some neurotropic agents under experimental hypodynamia

Woo D.V.; Christian J.E.; Schnell R.C., 1979: Pharmacological activity comparisons of barbiturates and their silicon analogs

Kowalczyk Bronisz S.H., 1980: Pharmacological activity in the group of new pyrido 2 3 c 1 2 thiazine 1 1 di oxide derivatives

Kowalczyk Bronisz S.H., 1984: Pharmacological activity of 3 5 barbiturylopropanesulfonic acid derivatives

Satta M.; Peana A.; Sparatore A.; Alamanni M.C., 1986: Pharmacological activity of 3 6 disubstituted 1 lupinylquinoxalin 2 1h ones

Savaki, H. E.; Cunha, J.; Carlini, E. A.; Kephalas, T. A., 1976: Pharmacological activity of 3 fractions obtained by smoking cannabis through a water pipe

Yamamoto I.; Marimatsu S.; Watanabe K.; Yoshimura H., 1981: Pharmacological activity of 8 alpha 9 alpha epoxy hexa hydro cannabinol and 8 beta 9 beta epoxy hexa hydro cannabinol in mice

Anderson W.G.; Kam S T., 1985: Pharmacological activity of acc 7513 n 2 2 6 dimethoxyphenoxyethyl 2 2 methoxyphenoxyethanaminium chloride a selective alpha adrenoceptor and 5 hydroxytryptamine receptor blocking agent

Mensah-Dwumah, M.; Daly, J. W., 1978: Pharmacological activity of alkaloids from poison dart frogs dendrobatidae

Dunn J.P.; Henkel J.G.; Gianutsos G., 1986: Pharmacological activity of amantadine effect of n alkyl substitution

Thakar, K. A.; Dumir, A. B., 1978: Pharmacological activity of bis coumarin oxy alkanes bis 1 2 benzisoxazoloxy alkanes and bis benzo furan oxy alkanes and their unsymmetric compounds di sodium cromoglycate analogs

Saratikov A.S.; Poltavchenko Yu A., 1982: Pharmacological activity of camphane derivatives

Kurbat, N. M.; Evets, M. A.; Korablev, M. V., 1986: Pharmacological activity of cytochrome c

Di Simplicio P.; Lampariello L.R.; Segre G., 1979: Pharmacological activity of epinephrine bound to glass beads

De Freitas J.C.; Marsiglio A.F., 1986: Pharmacological activity of extracts of some marine algae from the brazilian coast

Pirisino R.; Bianchini F.; Banchelli G.; Ignesti G.; Raimondi L.; Pecori Vettori L.; Rafanelli D., 1986: Pharmacological activity of fppo 28 2 phenyl 4 ethyl 4 7 dihydropyrazolo 1 5 a pyrimidin 7 one a new non steroid anti inflammatory agent

Buydens L.; Massart D.L.; Geerlings P., 1986: Pharmacological activity of neuroleptic drugs and physicochemical topological and quantum chemically calculated parameters a quantitative structure activity relationship study

Rauckman, E. J.; Rosen, G. M.; Lefkowitz, R. J., 1976: Pharmacological activity of nitroxide analogs of di chloro isoproterenol and propranolol

Perez C.; Mondelo N.; Stefano F.J.; Lores Arnaiz J., 1988: Pharmacological activity of novel alkylsulfonylaryl 1 substituted 1 4 benzodiazepine derivatives

Horioka, M.; Aoyama, T.; Karasawa, H., 1977: Pharmacological activity of propantheline bromide mixed with anti acids in guinea pigs and human

Omini, C.; Pasargiklian, R.; Folco, G. C.; Fano, M.; Bertie, F., 1978: Pharmacological activity of prostaglandin i 2 and its metabolite 6 oxo prostaglandin f 1 alpha on human uterus and fallopian tubes

Rodriguez R.; Lasheras B.; Cenarruzabeitia E., 1986: Pharmacological activity of prunus spinosa on isolated tissue preparations

Atremenko, G. N.; Vikhlyaev-Yu, I.; Kucherova, N. F.; Borisova, L. N., 1976: Pharmacological activity of pyrimido indole derivatives

Yamamoto I.; Tanaka T.; Watanabe K.; Narimatsu S.; Yoshimura H., 1986: Pharmacological activity of side chain hydroxylated metabolites of delta 9 tetrahydrocannabinol in mice

Krakovskii M.E.; Khakimov Z.Z., 1983: Pharmacological activity of some drugs in rats with nephrectomy

Korkhov, V. V.; Nikitina, G. V., 1978: Pharmacological activity of some progesterone derivatives

Perretti F.; Pirisino R.; Pecori Vettori L.; Auzzi G.; Bruni F.; Costanzo A.; Matucci M.; Longo G.; Messori A., 1987: Pharmacological activity of some pyrrolo and pyrazolo pyrimidine derivatives

Bagaeva S.G.; Lazareva D.N.; Davydova V.A.; Tolstikov G.A.; Miftakhov M.S.; Sidorov N.N.; Valeev F.A., 1986: Pharmacological activity of synthetic prostaglandin analogs

Satta M.; Peana A.; Alamanni M.C.; Pirisino G.; Savelli F., 1986: Pharmacological activity of tert aminoalkyl derivatives of quinoxalinones azaquinoxalinones and diazaquinoxalinones

Johnson J.M.; Lemberger L.; Novotny M.; Forney R.B.; Dalton W.S.; Maskarinec M.P., 1984: Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta 9 tetra hydro cannabinol in mice

Cohen M.L.; Kurz K.D.; Mason N.R.; Fuller R.W.; Marzoni G.P.; Garbrecht W.L., 1985: Pharmacological activity of the isomers of ly 53857 potent and selective 5 hydroxytryptamine 2 receptor antagonists

Samvelyan V.M.; Kazaryan S.A.; Matevosyan L.A.; Gevondyan A.I.; Mndzhoyan O.L., 1985: Pharmacological activity of the new dipeptide n nicotinoyl dl leucine

Al'tshuler R.A.; Mashkovskii M.D., 1980: Pharmacological activity of the optical isomers of sydnocarb

Pedigo N.W.Jr, 1988: Pharmacological adaptations and muscarinic receptor plasticity in hypothalamus of senescent rats treated chronically with cholinergic drugs

Haroutunian V.; Kanof P.; Davis K.L., 1985: Pharmacological alleviation of cholinergic lesion induced memory deficits in rats

Songsiridej V.; Busse W.W.; Buckner C.K., 1983: Pharmacological alteration of antigen induced contraction of lung parenchymal strips isolated from the actively sensitized guinea pig

Hand J.M.; Will J.A.; Buckner C.K., 1982: Pharmacological alteration of antigen induced contraction of pulmonary arteries isolated from the actively sensitized guinea pig

Yam J.; Roberts R.J., 1979: Pharmacological alteration of oxygen induced lung toxicity

Wichmann, J.; Loeser, R.; Diemer, H. P.; Lochner, W., 1978: Pharmacological alterations of coronary collateral circulation implication to the steal phenomenon

Petrowski S.; Nyhan W.L.; Reznik V.; Sweetman L.; Kulovich S.; Wolff J.; Jones G., 1987: Pharmacological amino acid acylation in the acute hyperammonemia of propionic acidemia

Bastian G.; Royer R., 1984: Pharmacological analogy of benzo flavones and carbonyl derivatives of phenyl naphthofurans

Saegusa K.; Furukawa Y.; Chiba S., 1986: Pharmacological analyses of hydralazine induced cardiac action in intact dogs and isolated blood perfused canine atria

Sinanovic S.; Chiba S., 1987: Pharmacological analysis of 5 ht induced vasoconstriction in isolated perfused dog skeletal muscle arteries

Edvinsson, L.; Hardebo, J. E.; Owman, C., 1978: Pharmacological analysis of 5 hydroxy tryptamine receptors in isolated intra cranial and extracranial vessels of cat and man

Cooke H.J.; Carey H.V., 1985: Pharmacological analysis of 5 hydroxytryptamine actions on guinea pig ileal mucosa

Engberg G.; Svensson T.H., 1980: Pharmacological analysis of a cholinergic receptor mediated regulation of brain norepinephrine neurons

Takenaga K., 1985: Pharmacological analysis of aggravation of reserpine ulcer by hydralazine in rats

Luttinger D.; Ferrari R.; Perrone M.H.; Haubrich D.R., 1985: Pharmacological analysis of alpha 2 adrenergic mechanisms in nociception and ataxia

Sandberg, D. E.; Segal, M., 1978: Pharmacological analysis of analgesia and self stimulation elicited by electrical stimulation of catecholamine nuclei in the rat brain

Saito A.; Ishikawa T.; Masaki T.; Kimura S.; Goto K., 1986: Pharmacological analysis of autonomic innervation of the right atria of rats and guinea pigs demonstration of nonadrenergic noncholinergic nerves

Berdeaux A.; Duhaze P.; Giudicelli J F., 1982: Pharmacological analysis of beta adrenoceptor blockade induced coronary blood flow re distribution in dogs using levo penbutolol

Black J.W.; Gerskowitch V.P.; Leff P.; Shankley N.P., 1985: Pharmacological analysis of beta adrenoceptor mediated agonism in the guinea pig isolated right atrium

Kobzar, G. T., 1978: Pharmacological analysis of biphasic postsynaptic potentials in identified neuron of the mollusk planorbarius corneus

Ovcharov, R.; Bantoutova, I.; Kobourova, K., 1976: Pharmacological analysis of certain mechanisms of morphine addiction

Akahane K.; Furukawa Y.; Ogiwara Y.; Haniuda M.; Takeda M.; Chiba S., 1987: Pharmacological analysis of chronotropic and inotropic response to diazepam in the isolated blood perfused canine atrium

Medvbedev, B. A., 1977: Pharmacological analysis of clofelin

Ariel M.; Daw N.W., 1982: Pharmacological analysis of directionally sensitive rabbit retinal ganglion cells

Beleslin, D.; Samardzic, R., 1976: Pharmacological analysis of gross behavioral effects of eserine and neostigmine injected into the cerebral ventricles of unanesthetized cats

Parnham M.J.; Bittner C., 1986: Pharmacological analysis of guinea pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan

Poshivalov V.P., 1979: Pharmacological analysis of hierarchical relations in mice

Colpaert F.C.; Bervoets K.J.W.; Van Den Hoogen R.H.W.M., 1987: Pharmacological analysis of hyperventilation in arthritic rats

He J.; Et Al, 1984: Pharmacological analysis of injection isoprenaline adrenaline noradrenaline triad

Hunter J.C.; Kilpatrick G.J.; Brown J.R., 1987: Pharmacological analysis of iodine 125 bolton and hunter labelled eledoisin binding sites in rat spinal cord by quantitative autoradiography

Talalaenko, A. N., 1976: Pharmacological analysis of mono aminergic effects of the amygdaloid complex on the food procuring conditioned reaction of rats

Talalaenko A.N.; Krivobok G.K.; Boreisha I.K., 1980: Pharmacological analysis of mono aminergic mechanisms of medical hypothalamus in food procuring conditioned reflexes in rats

Nilova T.N.; Vashetko R.V.; Khegai M.D., 1988: Pharmacological analysis of morphofunctional changes of the pancreatic adrenergic structures during injury of its endocrine and exocrine sections

Black J.W.; Shankley N.P., 1985: Pharmacological analysis of muscarinic receptors coupled to oxyntic cell secretion in the mouse stomach

Begeka, A. D., 1978: Pharmacological analysis of nervous pathways of transmission of hypothalamic influences on cardiac electrical activity

Klinge E.; Alaranta S.; Sjostrand N.O., 1988: Pharmacological analysis of nicotinic relaxation of bovine retractor penis muscle

Iwasawa, Y.; Gillis, C. N., 1974: Pharmacological analysis of norepinephrine and 5 hydroxy tryptamine removal from the pulmonary circulation differentiation of uptake sites for each amine

Altiere R.J.; Douglas J.S.; Gillis C.N., 1983: Pharmacological analysis of norepinephrine responses in rabbit pulmonary blood vessels

Osadchii L.I., 1980: Pharmacological analysis of physiological mechanisms in orthostatic tolerance

Wood, J. D.; Brann, L. R., 1986: Pharmacological analysis of rebound excitation in large intestine of piebald mouse model for hirschsprung's disease

Debowy, J.; Dynarowicz, I.; Garbulinski, T., 1976: Pharmacological analysis of regulation of phospho creatine and atp metabolism in resting skeletal muscle

Gedevanishvili, M. D.; Tsutsunava, L. E., 1978: Pharmacological analysis of serotonin growth stimulating activity on the proliferation of cell cultures

Bul'on V.V., 1988: Pharmacological analysis of serotonin involvement in the central mechanisms of the development of neurogenic gastric lesions in rats

Drust E.G.; Connor J.D., 1983: Pharmacological analysis of shaking behavior induced by enkephalins trh or serotonin in rats evidence for different mechanisms

Arefolov, V. A.; Pidevich, I. N.; Panasyuk, L. V.; Firsov, V. K., 1975: Pharmacological analysis of some adrenomimetic effects of serotonin

Kalix, P.; Mcafee, D. A.; Schorderet, M.; Greengard, P., 1974: Pharmacological analysis of synaptically mediated increase in cyclic amp in rabbit superior cervical ganglion

Debowy, J.; Dejneka, J.; Zieba, D., 1976: Pharmacological analysis of the abomasum rumen reflex in sheep

Noordewier, B.; Bailie, M. D.; Hook, J. B., 1978: Pharmacological analysis of the action of diuretics in the new born pig

Lokhandwala M.F.; Watkins H.O.; Sabouni M.H.; Alkadhi K.A., 1985: Pharmacological analysis of the actions of skf 82526 6 chloro 2 3 4 5 tetrahydro 1 4 hydroxyphenyl 1h 3 benzazepine 7 8 diol on cardiovascular dopamine receptors

Dutov A.A.; Karpov V.N.; Tolpyshev B.A.; Gladun V.N., 1987: Pharmacological analysis of the anticonvulsive effect of cavinton

Woolverton W.L.; Kamien J.B.; Goldberg L.I., 1987: Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys

Tricklebank M.D.; Middlemiss D.N.; Neill J., 1986: Pharmacological analysis of the behavioral and thermoregulatory effects of the putative 5 hydroxytryptamine 1 receptor agonist ru 24969 in the rat

Dougall I.G.; Leff P., 1987: Pharmacological analysis of the calcium dependence of mu receptor agonism

Hattori Y.; Sakuma I.; Nakao Y.; Kanno M., 1987: Pharmacological analysis of the cardiac actions of xamoterol a beta adrenoceptor antagonist with partial agonistic activity in guinea pig heart evidence for involvement of adenylate cyclase system in its cardiac stimulant actions

Branchevskii L.L., 1980: Pharmacological analysis of the cardio stimulant action of mesatone

Bousquet P.; Feldman J.; Bloch R.; Schwartz J., 1984: Pharmacological analysis of the central cardio vascular effects of gamma amino butyric acid analogs

Chamouard J M.; Meyrignac C.; Barre J.; Blatrix C.; Tillement J P., 1983: Pharmacological analysis of the difficulties encountered during anti epileptic treatment

Zharkovskii A.M.; Klyainrok Z., 1981: Pharmacological analysis of the effect of homo vanillic acid on rat behavior

Fontaine J.; Lebrun P., 1988: Pharmacological analysis of the effects of bay k 8644 and organic calcium antagonists on the mouse isolated distal colon

Hay, A. M., 1977: Pharmacological analysis of the effects of metoclopramide on the guinea pig isolated stomach

Fontaine J.; Reuse J., 1979: Pharmacological analysis of the effects of metoclopramide on the trans murally stimulated guinea pig ileum

Fontaine, J.; Reuse, J. , 1976: Pharmacological analysis of the effects of procaine and procainamide on the guinea pig ileum in vitro

Fontaine, J.; Reuse, J., 1978: Pharmacological analysis of the effects of substituted benzamides on the isolated guinea pig ileum study of metoclopramide sulpiride bromopride tiapride and sultopride

Val'dman A.V.; Medvedev O.S., 1984: Pharmacological analysis of the emotional behavior cardiovascular interactions

Cheronis J.C.; Erinoff L.; Heller A.; Hoffmann P.C., 1979: Pharmacological analysis of the functional ontogeny of the nigro striatal dopaminergic neurons

Black J.W.; Shankley N.P., 1986: Pharmacological analysis of the inhibition by pirenzepine and atropine of vagal stimulated acid secretion in the isolated stomach of the mouse

Rylov A.L., 1981: Pharmacological analysis of the inhibitory effect of the anti nociceptive system on avoidance behavior in rabbits

Barrett V.J.; Leff P.; Martin G.R.; Richardson P.J., 1986: Pharmacological analysis of the interaction between bay k 8644 and 5 hydroxytryptamine in rabbit aorta

Selivanova, A. T., 1976: Pharmacological analysis of the interrelation between short term and long term memory in animals with conditioned reflex systems

Haley D.A.; Thompson R.F.; Madden J.Iv, 1988: Pharmacological analysis of the magnocellular red nucleus during classical conditioning of the rabbit nictitating membrane response

Hachisu, M.; Shitoh, K.; Sekizawa, Y.; Koeda, T., 1980: Pharmacological analysis of the mechanism of action of phenthiazamine a piscine anesthetic

Demina L.M.; Zbarskaya I.S.; Pidevich I.N., 1981: Pharmacological analysis of the mechanism of development of serotonin induced diarrhea in mice

Black J.W.; Shankley N.P., 1985: Pharmacological analysis of the muscarinic receptors involved when mcn a 343 stimulates acid secretion in the mouse isolated stomach

Luscombe G.; Jenner P.; Marsden C.D., 1981: Pharmacological analysis of the myo clonus induced by 5 hydroxy tryptophan in the guinea pig suggests the presence of multiple 5 hydroxy tryptamine receptors in the brain

Ojewole J.A.O., 1984: Pharmacological analysis of the neuro muscular properties of di ethyl carbamazine citrate in vitro

Lima L.; Sourkes T.L., 1986: Pharmacological analysis of the neurotransmitter mechanisms regulating phenylethanolamine n methyltransferase in the adrenal gland

Zavodskaya I.S.; Moreva E.V.; Migas E.A.; Zabrodin O.N., 1985: Pharmacological analysis of the norepinephrine role in the experimental gastric ulceration

Kozlovskii V.L., 1986: Pharmacological analysis of the ontogenetic peculiarities of the functional activity of glial and neuronal gaba uptake receptors and the activity of gaba t in the hippocampus of rats

Vlasova N.V., 1987: Pharmacological analysis of the participation of ethanol oxidizing enzymatic systems in ethanol metabolism at different stages of experimental alcoholism

Varkov A.I., 1985: Pharmacological analysis of the participation of the catecholaminergic system in the development of the abstinent syndrome in rats

Belesin, D., 1977: Pharmacological analysis of the pendular movements appearing during the peristaltic block of the guinea pig isolated ileum produced by calcium

Black J.W.; Leff P.; Shankley N.P., 1985: Pharmacological analysis of the pentagastrin tiotidine interaction in the mouse isolated stomach

Beleslin, D.; Samardzic, R., 1977: Pharmacological analysis of the peristaltic block produced by magnesium applied to serosal and mucosal surface of the guinea pig isolated ileum

Beleslin, D.; Samardzic, R.; Malobabic, Z., 1976: Pharmacological analysis of the peristaltic blockade of guinea pig isolated ileum produced by tetra methyl ammonium

Shannon H.E., 1982: Pharmacological analysis of the phencyclidine like discriminative stimulus properties of narcotic derivatives in rats

Adenekan O.O.; Tayo F.M., 1985: Pharmacological analysis of the postjunctional alpha adrenoceptors of the rat anococcygeus muscle and vas deferens

Voronov I.B.; Zimin A.L.; Rukoyatkina N.I., 1984: Pharmacological analysis of the regulation of the length of respiratory cycle phases

Slack B.E.; Downie J.W., 1983: Pharmacological analysis of the responses of the feline urethra to autonomic nerve stimulation

Cortijo J.; Esplugues J.; Morcillo E.J.; Perpina M., 1984: Pharmacological analysis of the responsiveness of guinea pig lung parenchymal strip to dopamine

Bekhtereva Z.P., 1980: Pharmacological analysis of the role of dorsal hippocampus adrenergic effects in the central mechanisms of ovulation and compensatory hypertrophy of rat ovaries

Tanaka S.; Akira T.; Tabata M., 1984: Pharmacological analysis of the traditional chinese prescription goreisan ryo


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close